curriculum vitae name xianglin l. du, mb, ms, phd · pdf filecurriculum vitae update: october...

C.V. for Xianglin Du, Ph.D.

of 40

CURRICULUM VITAE

Update: October 5, 2017

NAME: Xianglin L. Du, MB, MS, PhD

PRESENT POSITION Professor of Epidemiology

& ADDRESS: School of Public Health

Department of Epidemiology, Human Genetics, and Environmental Sciences

The University of Texas Health Science Center at Houston (UTHealth)

1200 Pressler Street, RAS-E631

Houston, Texas 77030, USA.

Tel: (713) 500 9956; Fax: (713) 500 9264

E-mail: [email protected]

EDUCATION:

Sep. 1979 – June 1984 MB (Bachelor of Medicine) in Medicine

Medical School/School of Public Health

Anhui Medical University, China.

Sep. 1984 – June 1987 MS (Master of Science) in Clinical Epidemiology

School of Health Services Management


July 1990 – June 1991 World Health Organization Fellow

School of Medicine and Health Sciences

University of Newcastle-upon-Tyne, England, UK.

May 1993 – June 1993 Visiting Research Fellow, Division on Aging

Harvard University Medical School

Boston, Massachusetts, USA.

July 1993 – Jan. 1997 Ph.D. in Epidemiology and Public Health

School of Epidemiology and Health Sciences

University of Manchester Medical School, England, UK.

EMPLOYMENT AND POSITIONS HELD:

Sep. 2012 – present: Professor (with Tenure), Department of Epidemiology, Human Genetics, and Environmental

Sciences, School of Public Health, University of Texas Health Science Center (UTHealth), Houston, Texas, USA.

Jan. 2004 – Aug. 2012: Associate Professor (on Tenure-Track in 2004-2009 and with Award of Tenure effective

from September 1, 2009), Division of Epidemiology, Human Genetics & Environmental Sciences (primary appointment),

with membership in the Center for Health Services Research (since March 2004), adjunct Faculty in the UT-Graduate

School of Biomedical Sciences (since September 2007), and secondary Faculty appointment in the Division of

Management, Policy and Community Health (since June 2008), School of Public Health, University of Texas Health

Science Center, Houston, Texas, USA.

Sep. 2000 – Dec. 2003: Assistant Professor (on Tenure-Track), Department of Internal Medicine, with adjunct

faculty appointment in the Department of Preventive Medicine and Community Health, Associate Member of the

Graduate School of Biomedical Sciences, and Fellow of the Sealy Center on Aging, University of Texas Medical Branch,

Galveston, Texas, USA.

mailto:[email protected]


of 40

Jul. 1999 – Aug. 2000: Assistant Professor (on Non Tenure-Track), Department of Internal Medicine, University

of Texas Medical Branch, Galveston, Texas, USA.

Feb. 1997 – Jun. 1999: Postdoctoral Fellow and Epidemiologist, Sealy Center on Aging, University of Texas

Medical Branch, Galveston, Texas, USA.

July 1993 – Jan. 1997: Research Fellow and Ph.D. candidate, East Lancashire stroke prevention project, School of

Epidemiology & Health Sciences, University of Manchester Medical School, England.

July 1993 – June 1995: Clinical Research Fellow, Manchester Center, International Case-Control Study of Low-

dose Oral Contraceptives & Women Health, Univ. of Manchester Medical School, England.

May – June 1993: Visiting Research Fellow, Division on Aging, Harvard University Medical School, Boston,

Massachusetts, USA.

July 1990 – Apr. 1993: World Health Organization Fellow and Research fellow, The Assessment of Outcomes of

Health Care in the Elderly, Departments of Medicine (Geriatrics), and Public Health and Epidemiology, University of

Newcastle upon Tyne, England.

July 1987 – June 1990: Instructor, Department of Social Medicine and Clinical Epidemiology, Anhui Medical

University, China.

Sep. 1984 – June 1987: Graduate Research Assistant, Department of Social Medicine and Clinical Epidemiology,


HONORS AND AWARDS:

Research Awards:

1990 World Health Organization Fellowship Award (1990-91).

1996 International Epidemiology Association Travel Scholarship Award.

2000 First prize award, poster presentations, Annual Health Services and Outcomes Research

Conference, Houston, Texas, USA, November 3, 2000.

2004 Excellence in Research Award, Univ. of Texas School of Public Health, Houston, Texas, USA.



2006 Best abstracts award (selected from over 1,600), paper entitled “Racial Disparities and

Socioeconomic Status in Association with Survival in Older Men with Local/Regional Stage

Prostate Cancer” at the AcademyHealth Annual Research Meeting, June 2006, Seattle, WA.


2008 Excellence in Research Incentive Award, UT-School of Public Health, Houston, Texas, USA.






2014 Excellence in Research Incentive Award, UTHealth-School of Public Health, Houston, Texas, USA.



Teaching Awards:

2008 John P. McGovern Outstanding Teacher for 2008, ‘Teacher of the Year’, selected by the students of the

University of Texas (UT) School of Public Health, Houston, Texas, USA.

2009 Dean’s Teaching Excellence Award, UT-School of Public Health, Houston, Texas, USA.

2010 Dean’s Teaching Excellence Award, UT-School of Public Health, Houston, Texas, USA.


of 40

2012 Academic (Teaching and Service) Incentive Award, UT-School of Public Health, Houston, Texas, USA.

2013 Academic (Teaching and Service) Incentive Award, UT-School of Public Health, Houston, Texas, USA.

2014 Academic (Teaching and Service) Incentive Award, UTHealth-School of Public Health, Texas, USA.



PROFESSIONAL SERVICES:

I. Membership in Professional Societies:

Member of the British Society for Social Medicine (1996-2001)

Member of the American Association for Health Services Research (1998)

Member of the American Society for Epidemiologic Research (1998-2004)

Member of the Gerontological Society of America (1999-2003)

Member of the Academy for Health Services Research (2005-2008)

Member of American Heart Association and American Stroke Association (2008-2009)

II. Reviewer for the Peer-Reviewed Professional Journals (Regular, Periodic or Occasional Review):

Name of the Peer-Reviewed Journals Year of Service

1. Journal of Epidemiology & Community Health 1996 - present

2. American Journal of Managed Care 1997 - present

3. Journal of Aging and Health 1997 - present

4. Journal of Health Care for the Poor and Underserved 1997 - present

5. Medical Care 1999 - present

6. Cancer 1999 - present

7. Bio-Med Central Cancer 1999 - present

8. Annals of Epidemiology 2000 - present

9. Journal of Clinical Epidemiology 2000 - present

10. Journal of Clinical Oncology 2000 - present

11. Drugs & Aging 2001 - present

12. Public Library of Science 2001 - present

13. American Journal of Public Health 2004 - present

14. Journal of the National Cancer Institute 2005 - present

15. International Journal of Gynecological Cancer 2006 - present

16. Women’s Health Issues 2006 - present

17. Joint Commission Journal on Quality & Patient Safety 2007 - present

18. International Journal of Radiation Oncology, Biology, Physics 2007 - present

19. The Open Health Services & Policy Journal 2007 - present

20. Cancer Epidemiology, Biomarkers & Prevention 2007 - present

21. Social Science & Medicine 2008 - present

22. Journal of Health & Place 2008 - present

23. Journal of Surgical Oncology 2008 - present

24. Acta Oncologica 2008 - present

25. Clinical Medicine: Oncology 2008 - present

26. American Journal of Epidemiology 2009 - present

27. Radiation Oncology 2009 - present

28. Acta Obstetricia et Gynecologica Scandinavica 2009 - present

29. International Journal of Health Geographics 2009 - present

30. The Open Pharmocoeconomics & Health Economics Journal 2009 - present

31. JAMA Internal Medicine (formerly Archives of Internal Medicine) 2009 - present

32. Pharmacy and Therapeutics 2009 - present

33. Clinical Medicine Reviews in Oncology 2010 - present


of 40

34. Therapeutics and Clinical Risk Management 2010 - present

35. Journal of the American Geriatrics Society 2010 - present

36. BMC Public Health 2010 - present

37. European Journal of Clinical & Medical Oncology 2010 - present

38. Value in Health 2010 - present

39. British Journal of Cancer 2011 - present

40. Journal of Immigrant and Minority Health 2011 - present

41. Journal of General Internal Medicine 2011 - present

42. American Journal of Men's Health 2011 - present

43. Breast Cancer Research and Treatment 2012 - present

44. Leukemia and Lymphoma 2012 - present

45. American Journal of Pharmacy Benefits 2012 - present

46. International Journal of Surgical Oncology 2012 - present

47. Archives of Gerontology and Geriatrics 2012 - present

48. Journal of Infection and Public Health 2013 - present

49. Clinical Cancer Research 2013 - present

50. Texas Public Health Journal 2013 - present

51. Annals of Internal Medicine 2013 - present

52. International Journal of Women's Health 2013 - present

53. Journal of Gerontology & Geriatric Research 2014 - present

54. Journal of Clinical Gastroenterology 2014 - present

55. Clinical and Experimental Medicine 2014 - present

56. PLOS ONE 2014 - present

57. Cancer Causes and Control 2014 - present

58. Gynecologic Oncology 2014 - present

59. Heart 2015 - present

60. Cancer Epidemiology 2015 - present

61. Expert Opinion on Drug Safety 2015 - present

62. International Journal of Oncology 2015 - present

63. Expert Review of Pharmacoeconomics & Outcomes Research 2015 - present

64. Pharmacoepidemiology and Drug Safety 2015 - present

65. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2015 - present

66. Mayo Clinic Proceedings 2015 - present

67. International Journal of Cancer 2016 - present

68. British Journal of Clinical Pharmacology 2017 - present

69. JCO Clinical Cancer Informatics 2017 - present

70. Ethnicity and Health 2017 - present

Title of the Textbooks Reviewed by Invitation Year of Service

71. “Epidemiology: An Introduction for Public Health Practitioners”

proposal for Delmar-Cengage Learning, Health Care Publishing

Sep.-Oct. 2009

72. “Epidemiologic Research Methods in Public Health Practice”

textbook for Jones and Bartlett Publishers

Nov.-Dec. 2011

III. Services and Committees outside the Institution and for Federal Agencies:

Name of the Committee/Service Role Date of Service

1. Clinical Medicine Section of the Gerontological Society of America

Annual Scientific Meeting

Reviewer of the

Abstracts

2001-2003


of 40

2. Cancer Poster Session of the Gerontological Society of America 54th

Annual Scientific Meeting in Chicago, November 2001

Chair of the

Session

2001

3. Gerontological Society of America 54th Annual Scientific Meeting in

Chicago, November 2001 - Three sessions (End-of-Life, Pain, and

Physical Function).

Chair of the 3

sessions

2001

4. American Public Health Association (APHA) Annual

Scientific Meeting

Reviewer of the

Abstracts

2005, 2007, 2008

5. Research Advisory Panel, VA Parkinson’s Disease Research,

Education and Clinical Center (PADRECC) at Houston, VA Medical

Center and Baylor College of Medicine, Houston, TX

Member of the

Advisory Panel

March 2006 -

December 2008

6. Member of Advisory Committee to the Texas Cancer Registry (TCR)

and Member of Texas Cancer Data Work Group (TCDWG), TCR,

Texas Department of State Health Services

Member July 2007 –

May 2016

7. Peer-reviewed Journal: The Open Health Services & Policy Journal Member of

Editorial Board

November 2007 -

November 2010

8. CDC (Centers for Disease Control and Prevention) Review Panel Reviewer April-May 2008

9. CDC (Centers for Disease Control and Prevention) Review Panel Reviewer April-May 2009

10. Comparative Effectiveness Research on Cancer, American Association

for Cancer Research Annual Conference on Cancer Prevention

Research, December 6-9, 2009, Houston, Texas.

Chairperson of the

Special Session on

CER

December 2009

11. Agency for Healthcare Research and Quality (AHRQ) Special

Emphasis Panel (iADAPT; RFA-HS-10-004 (R18))

Reviewer March-April 2010

12. AHRQ Healthcare Technology and Decision Sciences (HTDS) Study

Section

Reviewer May-June 2010

13. Agency for Healthcare Research and Quality (AHRQ) Special

Emphasis Panel (RFA-HS-10-020 (R01))

Reviewer May-June 2010

14. Peer-reviewed Journal: BMC Public Health Editorial Board

Associate Editor

August 2010 -

April 2013

15. Research Grants Council Hong Kong, China Reviewer March-April 2011

16. Peer-reviewed Journal: Epidemiology – Open Access Editorial Board

Associate Editor

June 2011-

May 2015

17. Foundation for Polish Science, Poland Reviewer April-May 2012

18. PCORI (Patient Centered Outcomes Research Institute) Phase-2 Grant

Review Panel

Scientific

Reviewer

October-

November 2012

19. NIH Health Delivery and Methodologies Special Emphasis Panel

(SEP)

Reviewer January-March

2014


of 40

20. 2014-2015 Komen Graduate Training in Disparities (GTDR) Grant

Full Applications

Scientific

Reviewer

January-February

2015

21. NIH Special Emphasis Panel (SEP) Reviewer May-June 2015

22. Cancer Research UK (United Kingdom) Reviewer July-August 2016

23. NIH Serious Adverse Drug Reaction Research Study Section Reviewer Feb.-March 2017

IV. Institutional and Community Services:

Name of the Committee/Service Role Term/Date of Service

1. Rehabilitation Science Core Faculty Committee,

University of Texas Medical Branch at Galveston

Member March 2002 - Dec. 2003

2. Admission Triage Committee, Division of Epidemiology, University of

Texas School of Public Health at Houston

Member July 2004 - August 2008

3. Curriculum Committee, Division of Epidemiology (now Department of

Epidemiology, Human Genetics, and Environmental Sciences),

University of Texas School of Public Health at Houston

Member Dec. 2004 - present

4. Faculty Search Committee for Health Services and Outcomes, Division

of Management, Policy and Community Health, SPH

Member 2005

5. Search Committee for Administrative Service Officer (ASO-III),

Division of Epidemiology, UT-SPH

Member August-October 2006

6. Sub-Committee on Teaching Assistant (TA) Allocation for

Epidemiology Courses, Division of Epidemiology, UT-SPH

Member July-August 2006

7. Advisory Committee of the UT-SPH Cancer Prevention &

Control Training & Career Development Program, Division of

Behavioral Science and Health Promotion, UT-SPH

Member April 2007 - present

8. IRB (Institutional Review Board) Committee (Committee for the

Protection of Human Subjects) of the University of Texas Health

Science Center in Houston

Member Sep. 2007 - Aug. 2016

(three 3-year terms)

9. Faculty Development Leave Committee,

University of Texas School of Public Health at Houston

Member September 2007 - Aug.

2009

10. Peer Review Panel of the UTSPH for the PRIME (Pilot Research

Investigations with Mentoring for Excellence) and Bridging and Near-

Miss Grant Funds, UT-SPH at Houston

Member September 2007 -

August 2009

(two-year term)

11. Search Committee for Four Epidemiology Faculty Positions, UTSPH Member May 2008 - June 2010

12. AAR Peer Reviewer for the UT-SPH Member Dec. 2008 - Jan. 2009

13. Search Committee for the Director of the Health Outcomes Research,

UTSPH

Member May 2009 - June 2010


of 40

14. Faculty Search Committee – Comparative Effectiveness /Outcomes

Research (10 Positions), UTSPH

Member Nov. 2010 - Aug. 2011

15. ‘Cancer Epidemiology Concentration’ Program Working Group,

UTSPH

Member Oct. 2011 - July 2012

16. Epidemiology Preliminary Exam Committee Member Aug. 2012 - July 2014

17. UT-SPH School-wide Tenure and Promotion (T&P) Committee Co-Chair April 2013 - Jan. 2014

18. UT-SPH School-wide Tenure and Promotion (T&P) Committee Chair Feb. 2014 - Feb. 2015

19. Faculty Search Committee at UT-SPH Brownsville Regional Campus –

Epi+Behavioral Sci joint Faculty with focus on CER, UTSPH

Member July 2015 - March 2016

20. Search Committee for UT-SPH Dallas Regional Dean, UTSPH Member January - Sep. 2016

21. Epidemiology Preliminary Exam Committee Member Aug. 2016 - present

TEACHING ACTIVITIES:

Part-A: Teaching Responsibilities at UTMB in Galveston (in 1999-2003):

I. Class Teaching at UTMB (University of Texas Medical Branch at Galveston):

Co-Instructor, the course module PMCH6330 “Introduction to Epidemiology”, 1999 at UTMB.




Guest Lecturer, the course module PMCH6330 “Introduction to Epidemiology”, 2004 at UTMB.

Lead Instructor: Module PMCH6215 “Epidemiologic Research Using Large Public Databases”,

Spring Semester 2002 (a new course created and taught) at UTMB.

Lead Instructor: Module PMCH6215 “Epidemiologic Research Using Large Public Databases”,

Fall Semester, 2003 at UTMB.

II. Mentoring and Committee Advising:

Mentor, for a second year clinical geriatric fellow, 1999.

Mentor, for a first year medical student on the Summer Medical Research Project, 2000.

Mentor, for a postdoctoral fellow (Max E. Otiniano, MD, MPH) on the minority aging

projects, March 2001 – August 2002.

Mentor, for a geriatric and oncology fellow (Cynthia Osborne, MD) on the breast cancer

research, August 2001 – July 2002.

Mentor, for a clinical oncologist (Dennie V. Jones, MD) working on the NIH minority

supplement grant, March 2002 – December 2003.

Part-B: Teaching Responsibilities at UTHealth in Houston (from January 2004 to present):

I. Class Teaching at UT-SPH (University of Texas School of Public Health):

Course Number and Name Role (% effort) Semester/

Year

Number of

students

1. PH2711-Advanced Epidemiologic Methods II

(guest lecture on the Cox survival analysis)

Guest Lecturer Spring 2004 19


of 40

2. PH2998-Epidemiologic Research Using Claims-Based

Healthcare Data

Lead Instructor (100%) Fall 2004 10

3. PH2710-Advanced Epidemiologic Methods I Co-Instructor (10%) Fall 2004 44

4. PH2610-Introduction to Epidemiology Guest Lecturer Fall 2004 85

5. PMCH6215-Introduction to Epidemiology, UTMB Guest Lecturer Fall 2004 25

6. PH2710-Advanced Epidemiologic Methods I Co-Instructor (10%) Spring 2005 18

7. PH2711-Advanced Epidemiologic Methods II

(lecture on the Cox survival project)

Guest Lecturer Spring 2005 20

8. PH2998-Epidemiologic Study Using Claims-Based

Healthcare Data


9. PH2710-Advanced Epidemiologic Methods I Guest Lecturer Fall 2005 20


11. PH2610-Introduction to Epidemiology Lead Instructor (100%) Summer 2006 8


13. PH2610(ITV)-Introduction to Epidemiology Lead Instructor (100%) Summer 2007 12

14. PH2612-Introduction to Epidemiology for Majors Lead Instructor (100%) Fall 2007 41


16. PH2612-Introduction to Epidemiology for Majors Lead Instructor (100%) Fall 2008 34

17. PH2612-Introduction to Epidemiology for Majors Guest Lecturer Spring 2009 26

18. PH2612-Epidemiology I (ITV to all campuses) Lead Instructor (100%) Fall 2009 31

19. PH2612-Epidemiology I Guest Lecturer Spring 2010 18





24. PHM2612-Epidemiology I Lead Instructor (100%) Fall 2012 19


26. PHD2711-Epidemiology IV (ITV to all campuses) Guest Lecturer Spring 2014 12


28. PHD2990-Epidemiology Seminar (ITV to all

campuses)




campuses)




campuses)


33. PHM9996-Capstone Course (ITV to all campuses)Wed Lead Instructor (60%) Spring 2017 27

34. PHM9996-Capstone Course (ITV to all campuses)Thu Guest Lecturer Spring 2017 29

35. PHM9996-Capstone Course (ITV to all campuses) Guest Lecturer Summer 2017 40



campuses)


II. Individual Study (PH2999), Practicum (PH9997), Thesis (PH9998)/Dissertation (PH9999) Research:

Name of Students Degree Program

(major field)

Type of Teaching Credit

Hours

Semester/Year

1. Yan Xing PhD (health service) Individual Study 3 Summer 2004

2. Shenying Fang PhD (biostatistics) Practicum 3 Fall 2004

3. Liqian Liu MS (epidemiology) Individual Study 1 Summer 2005

4. Nidhi Rohatgi MS (epidemiology) Individual Study 3 Summer 2005

5. Matthew Shim PhD (epidemiology) Individual Study 4 Summer 2005


of 40

6. Nidhi Rohatgi MS (epidemiology) Thesis Research 2 Fall 2005

7. Evette Toney PhD (epidemiology) Individual Study 1 Fall 2005

8. Dale Hardy PhD (epidemiology) Individual Study 2 Fall 2005

9. Laurens Holmes DrPH (epidemiology) Individual Study 1 Spring 2006

10. Evette Toney PhD (epidemiology) Individual Study 5 Spring 2006

11. Amit Habbu MPH (epidemiology) Thesis Research 3 Spring 2006

12. Nidhi Rohatgi MS (epidemiology) Thesis Research 3 Spring 2006

13. Laurens Holmes DrPH (epidemiology) Dissertation Research 1 Spring 2006

14. Laurens Holmes DrPH (epidemiology) Dissertation Research 1 Summer 2006

15. Shenying Fang PhD (biostatistics) Practicum 4 Fall 2006

16. Ravi Chopra MS (epidemiology) Practicum 3 Fall 2006

17. Michelle Lacour MPH (epidemiology) Thesis Research 3 Fall 2006

18. David Yang MPH (epidemiology) Practicum 3 Spring 2007

19. Michelle Lacour MPH (epidemiology) Practicum 3 Spring 2007

20. Emily Bettis MPH (epidemiology) Practicum 3 Spring 2007

21. Michelle Lacour MPH (epidemiology) Thesis Research 3 Spring 2007

22. Yi Min PhD (biostatistics) Individual Study 2 Summer 2007

23. Stephen Gruschkus PhD (health service) Individual Study 2 Summer 2007

24. David Yang MPH (epidemiology) Individual Study 1 Summer 2007

25. Jessica Sun PhD (biostatistics) Individual Study 2 Summer 2007

26. Sachin Kamble MPH (epidemiology) Practicum 3 Summer 2007

27. Michelle Lacour MPH (epidemiology) Thesis Research 3 Summer 2007

28. Sachin Kamble MPH (epidemiology) Thesis Research 3 Fall 2007

29. Chung-Yuan Hu PhD (epidemiology) Practicum 1 Fall 2007

30. Arica White PhD (epidemiology) Individual Study 3 Fall 2007

31. Ravi Chopra MS (epidemiology) Thesis Research 3 Fall 2007

32. Michelle Lacour MPH (epidemiology) Thesis Research 5 Fall 2007

33. Kavita Sail PhD (health service) Individual Study 3 Spring 2008

34. Chung-Yuan Hu PhD (epidemiology) Individual Study 3 Spring 2008

35. Rui Xia PhD (biostatistics) Individual Study 3 Spring 2008

36. Arica White PhD (epidemiology) Individual Study 1 Spring 2008

37. Robin Lacour MPH (epidemiology) Thesis Research 9 Spring 2008

38. Emily Bettis MPH (epidemiology) Thesis Research 3 Spring 2008

39. Sachin Kamble MPH (epidemiology) Thesis Research 3 Spring 2008

40. David Yang MPH (epidemiology) Thesis Research 3 Spring 2008

41. Ravi Chopper MS (epidemiology) Thesis Research 3 Spring 2008

42. Chung-Yuan Hu PhD (epidemiology) Practicum 1 Spring 2008

43. Brian Badgwell MS (epidemiology) Individual Study 1 Summer 2008

44. Joyce Li MPH (epidemiology) Practicum 3 Summer 2008

45. Brady Moffett MPH (epidemiology) Practicum 3 Summer 2008

46. Nadia Barahmani MS (epidemiology) Thesis Research 5 Summer 2008

47. Brian Badgwell MS (epidemiology) Thesis Research 2 Summer 2008

48. Joyce Li MPH (epidemiology) Thesis Research 3 Summer 2008

49. Sachin Kamble MPH (epidemiology) Thesis Research 3 Summer 2008

50. Arica White PhD (epidemiology) Dissertation Research 3 Summer 2008

51. Monawar Hosain PhD (epidemiology) Dissertation Research 3 Summer 2008

52. Judith Wendt PhD (epidemiology) Individual Study 3 Fall 2008

53. Beatrix Foldi PhD (epidemiology) Individual Study 3 Fall 2008

54. Joyce Li MPH (epidemiology) Individual Study 3 Fall 2008

55. Chung-Yuan Hu PhD (epidemiology) Practicum 2 Fall 2008

56. Rita Sheth MPH (epidemiology) Practicum 3 Fall 2008

57. Nadia Barahmani MS (epidemiology) Thesis Research 3 Fall 2008

58. Emily Bettis MPH (epidemiology) Thesis Research 3 Fall 2008

59. Chung-Yuan Hu PhD (epidemiology) Dissertation Research 3 Fall 2008

60. Arica White PhD (epidemiology) Dissertation Research 3 Fall 2008

61. Stephen Gruschkus PhD (epidemiology) Dissertation Research 3 Fall 2008

62. Joyce Li MPH (epidemiology) Individual Study 3 Spring 2009


of 40

63. Chung-Yuan Hu PhD (epidemiology) Practicum 1 Spring 2009

64. David Yang MPH (epidemiology) Thesis Research 3 Spring 2009

65. Sachin Kamble MPH (epidemiology) Thesis Research 3 Spring 2009

66. Rita Sheth MPH (epidemiology) Thesis Research 3 Spring 2009

67. Brady Moffett MPH (epidemiology) Thesis Research 3 Spring 2009

68. Chung-Yuan Hu PhD (epidemiology) Dissertation Research 3 Spring 2009

69. Arica White PhD (epidemiology) Dissertation Research 3 Spring 2009

70. Stephen Gruschkus PhD (epidemiology) Dissertation Research 3 Spring 2009

71. Beatrix Foldi PhD (epidemiology) Dissertation Research 4 Spring 2009

72. Brady Moffett MPH (epidemiology) Thesis Research 3 Summer 2009

73. Arica White PhD (epidemiology) Dissertation Research 3 Summer 2009

74. Stephen Gruschkus PhD (epidemiology) Dissertation Research 3 Summer 2009

75. Michelle Ludwig PhD (epidemiology) Individual Study 4 Fall 2009

76. Brady Moffett MPH (epidemiology) Thesis Research 3 Fall 2009

77. Jessica Clague PhD (epidemiology) Dissertation Research 5 Fall 2009

78. Peter Abotchie DrPH (HPBS) Dissertation Research 3 Fall 2009

79. Chung-Yuan Hu PhD (epidemiology) Dissertation Research 3 Fall 2009

80. Michelle Ludwig PhD (epidemiology) Dissertation Research 5 Fall 2009

81. Brady Moffett MPH (epidemiology) Thesis Research 3 Spring 2010

82. Jessica Clague PhD (epidemiology) Dissertation Research 5 Spring 2010

83. Peter Abotchie DrPH (HPBS) Dissertation Research 4 Spring 2010

84. Chung-Yuan Hu PhD (epidemiology) Dissertation Research 3 Spring 2010

85. Michelle Ludwig PhD (epidemiology) Dissertation Research 3 Spring 2010

86. Chung-Yuan Hu PhD (epidemiology) Dissertation Research 1 Summer 2010

87. Michelle Ludwig PhD (epidemiology) Dissertation Research 3 Summer 2010

88. Chung-Yuan Hu PhD (epidemiology) Cancer Epi Using Medicare 2 Summer 2010

89. Zhannat Nurgalieva PhD (epidemiology) Cancer Disparity Research 3 Summer 2010


91. Zhannat Nurgalieva PhD (epidemiology) Dissertation Research 3 Spring 2011

92. Kathryn Kimbrough MPH in Epidemiology Practicum 3 Summer 2011

93. Zhannat Nurgalieva PhD (epidemiology) Dissertation Research 1 Summer 2011

94. Li Nan MS in Epidemiology Thesis Research 3 Fall 2011

95. Laitan O. Lansebe MPH in Epidemiology Practicum 3 Fall 2011

96. Adeniran A. Olaoya MPH in Epidemiology Practicum 3 Fall 2011

97. Zhannat Nurgalieva PhD (epidemiology) Dissertation Research 2 Fall 2011


99. Li Nan MS in Epidemiology Thesis Research 1 Spring 2012

100. Zhannat Nurgalieva PhD (epidemiology) Dissertation Research 2 Spring 2012

101. Saurav Suman MPH in Epidemiology Practicum 3 Spring 2012


103. Zhannat Nurgalieva PhD (epidemiology) Dissertation Research 2 Summer 2012

104. Saurav Suman MPH in Epidemiology Thesis Research 3 Summer 2012


106. Zhannat Nurgalieva PhD (epidemiology) Dissertation Research 1 Fall 2012

107. Tong, Liyue PhD (epidemiology) Dissertation Research 1 Fall 2012

108. Michelle Ludwig PhD (epidemiology) Dissertation Research 3 Spring 2013

109. Tong, Liyue PhD (epidemiology) Dissertation Research 3 Spring 2013


111. Jose Zevallos MPH (epidemiology) Individual Study 3 Summer 2013

112. Poonawalla, Insiya PhD (epidemiology) Dissertation Research 3 Fall 2013

113. Tong, Liyue PhD (epidemiology) Dissertation Research 3 Fall 2013


115. Mohammad Shakhatreh MPH in Epidemiology Thesis Research 3 Fall 2013

116. John Teke MS (Biostatistics) Thesis Research 1 Spring 2014

117. Poonawalla, Insiya PhD (epidemiology) Dissertation Research 3 Spring 2014

118. Mohammad Shakhatreh MPH in Epidemiology Thesis Research 3 Spring 2014

119. Tong, Liyue PhD (epidemiology) Dissertation Research 3 Spring 2014


of 40

120. Wang, Xin PhD (pharmacy) at Univ. of Houston Individual Study 3 Spring 2014

121. Poonawalla, Insiya PhD (epidemiology) Dissertation Research 3 Fall 2014

122. Chi Nguyen PhD (epidemiology) Dissertation Research 3 Fall 2014

123. Chen Ying PhD (epidemiology) Individual Study 3 Fall 2014

124. Xerxes Nozer Pundole PhD (epidemiology) Dissertation Research 5 Spring 2015

125. Poonawalla, Insiya PhD (epidemiology) Dissertation Research 3 Spring 2015

126. Chi Nguyen PhD (epidemiology) Dissertation Research 3 Spring 2015

127. Chen Ying PhD (epidemiology) Dissertation Research 3 Spring 2015

128. Joshua Swan MPH in Epidemiology Thesis Research 3 Summer 2015

129. Xerxes N. Pundole PhD (epidemiology) Dissertation Research 4 Fall 2015


131. Chen Ying PhD (epidemiology) Dissertation Research 3 Fall 2015

132. Shuangshuang Fu PhD (epidemiology Dissertation Research 3 Fall 2015

133. Xerxes N. Pundole PhD (epidemiology) Individual Study 4 Fall 2015

134. Xiaotao Zhang PhD (epidemiology) Individual Study 3 Fall 2015

135. Chi Nguyen PhD (epidemiology) Individual Study 2 Fall 2015

136. Kathy M. Abusager MPH in Epidemiology Practicum 3 Fall 2015

137. Aylin Tansel MPH in Epidemiology Thesis Research 3 Spring 2016

138. Joshua Swan MPH in Epidemiology Thesis Research 3 Spring 2016

139. Aylin Tansel MPH in Epidemiology Individual Study 3 Spring 2016

140. Xerxes N. Pundole PhD (epidemiology) Dissertation Research 2 Spring 2016

141. Chen Ying PhD (epidemiology) Dissertation Research 3 Spring 2016

142. Chi Nguyen PhD (epidemiology) Individual Study 3 Spring 2016

143. Xerxes N. Pundole PhD (epidemiology) Dissertation Research 3 Summer 2016

144. Chen Ying PhD (epidemiology) Dissertation Research 3 Summer 2016

145. Catherine Hambleton MPH in Epidemiology Practicum 1 Summer 2016

146. Aylin Tansel MPH in Epidemiology Thesis Research 3 Summer 2016


148. Christine N. Spencer PhD (epidemiology) Dissertation Research 1 Fall 2016

149. Xerxes N. Pundole PhD (epidemiology) Dissertation Research 3 Fall 2016

150. Chen Ying PhD (epidemiology) Dissertation Research 3 Fall 2016

151. Anand, Grace MPH in Epidemiology Practicum 3 Fall 2016


153. Shuangshuang Fu PhD (epidemiology Dissertation Research 2 Spring 2017

154. Christine N. Spencer PhD (epidemiology) Dissertation Research 3 Spring 2017

155. Chi Nguyen PhD (epidemiology) Dissertation Research 3 Spring 2017

156. Puja Aggarwal PhD (epidemiology) Dissertation Research 3 Spring 2017

157. Shuangshuang Fu PhD (epidemiology) Individual Study 1 Spring 2017

158. Naruhiko Ikoma MS in Epidemiology Thesis Research 2 Summer 2017

159. Christine N. Spencer PhD (epidemiology) Dissertation Research 3 Summer 2017

160. Puja Aggarwal PhD (epidemiology) Dissertation Research 3 Summer 2017

161. Shuangshuang Fu PhD (epidemiology Practicum 2 Fall 2017

162. Tam, Samantha (MD) MPH in Epidemiology Thesis Research 3 Fall 2017



165. Puja Aggarwal PhD (epidemiology) Dissertation Research 3 Fall 2017

III. Member of the Academic/Thesis/Dissertation Committees for Students:

Name of Students Degree Program

(type of doctoral committee)

Study Period Status or Month/Year of

Graduation

1. Lu Mei MS in Biostatistics (minor in Epi) Feb. 2004-Dec. 2004 Graduated in 12/2004

2. Kelly Merriman PhD in Epidemiology (dissertation) Sep. 2004-Nov.2007 Graduated in 11/2007

3. Liu Hui MS in Biostatistics (minor in Epi) Dec. 2004-Dec. 2005 Graduated in 12/2005

4. Liqian Liu MS in Epidemiology (thesis) Aug. 2004-Dec. 2005 Graduated in 12/2005


of 40

5. Yan Xing PhD in Biostatistics (minor in Epi) Sep. 2004-Aug. 2006 Passed qualifying exam

6. Shenying Fang PhD in Biostatistics (minor in Epi) Dec. 2004-Mar. 2006 Passed qualifying exam

7. Zhigang Duan PhD in Biostatistics (minor in Epi) Jan. 2005-Feb. 2006 Passed qualifying exam

8. Liz Ye Han MPH in Biostatistics (thesis) Mar. 2004-Mar. 2006 Graduated in 03/2006

9. Prashant Gundre MPH in community health Aug. 2004-Aug. 2005 Moved away/discontinued

10. Catherine Gomez MPH in health promotion Aug. 2004-Nov. 2010 Graduated in 11/2010

11. Xuemei Wang PhD in Biostatistics (minor in Epi) Oct. 2004- Aug. 2006 Passed qualifying exam

12. Mai Pham MPH in Health Service and Policy Aug. 2005-Aug. 2006 Moved away/discontinued

13. Julie S. Beaver MS in Biostatistics (minor in Epi) Oct. 2004-Dec. 2005 Graduated in 12/2005

14. Kai Sun MS in Biostatistics (minor in Epi) Aug. 2005-Aug. 2006 Graduated in 08/2006

15. Rui Xia MS in Biostatistics (minor in Epi) Aug. 2005-Aug. 2007 Graduated in 08/2007

16. Tuan Vo PhD in Epidemiology (dissertation) Jan. 2005-Aug. 2006 Graduated in 08/2006

17. Monawar Hosain PhD in Epidemiology (dissertation) Aug. 2005-Aug. 2008 Graduated in 08/2008

18. Sandra Olfert PhD in Epidemiology (dissertation) Aug. 2005-Mar. 2006 Graduated in 03/2006

19. Desiree Jones PhD in Epidemiology (dissertation) Aug. 2005-May 2006 Graduated in 05/2006

20. Mala Pande PhD in Epidemiology (dissertation) Sep. 2006-Nov. 2007 Graduated in 11/2007

21. Liu Mei PhD in Biostatistics (minor in Epi) Jun. 2006-Mar. 2008 Passed qualifying exam

22. Yu-Feng Lin DrPH in Health Services (dissertation) Oct. 2006-Jul. 2009 Graduated in 07/2009

23. Han Liu PhD in Molecular Epi (from GSBS) Nov. 2006-May 2007 Graduated MS in 05/2007

24. Ashwini Mhatre MS in Epidemiology (thesis) Nov. 2006-Nov. 2008 Graduated in 11/2008

25. Javier Berrios-Rivera MS in Epidemiology Jan. 2007-Jan. 2009 Moved away/discontinued

26. Min Yi PhD in Biostatistics (minor in Epi) Jan. 2007-Feb. 2009 Passed qualifying exam

27. Jun Liu PhD in Biostatistics (minor in Epi) Jan. 2007-Oct. 2009 Passed qualifying exam

Jun Liu PhD in Biostatistics (dissertation) Jan. 2012-Nov. 2012 Graduated in 11/2012

28. Kaiyan Jing MS in Biostatistics (minor in Epi) Feb. 2007-Mar. 2008 Graduated in 03/2008

29. Matthew Shim PhD in Epidemiology (dissertation) Feb. 2007-Jan. 2008 Graduated in 01/2008

30. Abeer B. Alsarraj MS in Epidemiology (thesis) Feb. 2008-Oct. 2009 Graduated in 10/2009

31. Scott Stover PhD in Health Policy (minor in Epi) Apr. 2007-Apri. 2010 Changed the program

32. Dawen Sui PhD in Biostatistics (minor in Epi) Mar. 2008-Mar. 2011 Changed the program

33. Ning Zhang MS in Biostatistics (minor in Epi) Mar. 2008-May 2012 Graduated in 05/2012

34. Rui Xia PhD in Biostatistics (minor in Epi) Apr. 2008-Mar. 2010 Passed qualifying exam

35. Kavita Sail PhD in Health Services (dissertation) May 2008-Apr. 2010 Graduated in 04/2010

36. Sofia De achaval MS in Epidemiology (thesis) Oct. 2008-Aug. 2009 Graduated in 08/2009

37. Saqr Hatem PhD in Health Policy (minor in Epi) Dec. 2008-Jun. 2009 Passed qualifying exam

38. Caimiao Wei PhD in Biostatistics (minor in Epi) Jan. 2009-Sep. 2010 Passed qualifying exam

Caimiao Wei PhD in Biostatistics (dissertation) May 2012-May 2015 Graduated in 05/2015

39. Ma Long PhD in Biostatistics (minor in Epi) Apr. 2009-Apr. 2011 Passed qualifying exam

40. Liu Mei PhD in Biostatistics (dissertation) Aug. 2009-May 2010 Graduated in 05/2010

41. Wang Gangduo MS in Biostatistics (minor in Epi) Aug. 2009-May 2012 Graduated in 05/2012

42. Niu Jiangong MS in Biostatistics (minor in Epi) Oct. 2009-Oct. 2011 Changed the program

43. Judith Wendt (MS) PhD in Epidemiology (dissertation) Dec 2009- May 2012 Graduated in 05/2012

44. Zhang, Xuan PhD in Biostatistics (minor in Epi) Mar. 2010-Feb. 2011 Passed qualifying exam

45. Yi Cai MS in Biostatistics (minor in Epi) Apr. 2010-Aug. 2011 Graduated in 08/2011

46. Bo He PhD in Biostatistics (minor in Epi) Apr. 2010-Oct. 2011 Passed qualifying exam

47. Marc Kowalkowski MS in Epidemiology (thesis) June 2010-Nov. 2010 Graduated in 11/2010

48. Panchal, Janki M PhD in Health Economics (dissertation) Oct. 2010-May 2012 Graduated in 05/2012

49. Wang Ying MS in Biostatistics (minor in Epi) Oct. 2010-July 2011 Graduated in 07/2011

50. Aditi Kadakia MS in pharmacy (Univ. of Houston) Mar. 2011-Aug. 2011 Graduated in 08/2011

51. Wang, Tao PhD in Biostatistics (minor in Epi) April 2011-Oct. 2012 Graduated in 10/2012

52. Duong T. Tran PhD in Epidemiology (dissertation) Sep. 2011-July 2013 Graduated in 07/2013

53. Lee Cheng PhD in Biostatistics (dissertation) Nov. 2011-Nov. 2012 Graduated in 11/2012

54. Jinhai Huo PhD in Health Services (dissertation) Jan. 2012-May 2013 Graduated in 05/2013

55. Hong Zhang PhD in Biostatistics (dissertation) Mar. 2012-May 2013 Graduated in 05/2013

56. Russell, Heidi (MD) PhD in Health Services (dissertation) July. 2012- July 2013 Graduated in 07/2013

57. Park, Minjeong PhD in Biostatistics (dissertation) Aug. 2012-Dec. 2013 Graduated in 12/2013

58. Adhikari, Deepak MS in Biostatistics (minor in Epi) Aug. 2012-July 2013 Graduated in 07/2013

59. Malla, Rashmi MS in Biostatistics (minor in Epi) Sep. 2012- May 2013 Graduated in 05/2013


of 40

60. Ling, Kok Yan MS in Biostatistics (minor in Epi) Oct. 2012- May 2013 Graduated in 05/2013

61. Yue Song MS in Biostatistics (minor in Epi) Jan. 2013-May 2013 Graduated in 05/2013

62. Yang Zhao MS in Biostatistics (minor in Epi) Jan. 2013-June 2013 Graduated in 06/2013

63. Marc Kowalkowski PhD in Epidemiology (dissertation) Feb. 2013-Aug. 2013 Graduated in 08/2013

64. John Teke MS in Biostatistics (minor in Epi) Feb. 2013-Aug. 2014 Graduated in 08/2014

65. Kim, Jung Hyun PhD in Health Services (dissertation) Aug. 2013-Dec. 2016 Graduated in 12/2016

66. Chung, Tong Han PhD in Health Services (dissertation) Aug. 2013-Aug. 2015 Graduated in 08/2015

67. Chuan Hong PhD in Biostatistics (dissertation) May 2014-May 2016 Graduated in 05/2016

68. Chuo, Ching-Yi PhD in Epidemiology (dissertation) Aug. 2014-Dec. 2016 Graduated in 12/2016

69. Rohan C. Parikh PhD in Health Services (dissertation) Aug. 2014-Aug. 2015 Graduated in 08/2015

70. Min-Ji Kwak DrPH in Health Services (dissertation) Nov. 2014-present

71. Maria A. Ukhanova PhD in Health Services (dissertation) Feb. 2015-present

72. Chen, Tsun-Hsuan (Joy) PhD in Environmental Sci(dissertation) Oct. 2015-present

73. Nancy M. Wood (MS) PhD in Health Services (dissertation) Oct. 2016-present

IV. Advisor and/or Supervisor of Academic/Thesis/Dissertation Committees for Students:

Name of Students

(degree before entry)

Degree Program

(type of doctoral committee)

Study Period Status or Month/Year

of Graduation*

1. Nidhi Rohatgi (MD) MS in Epidemiology (thesis) Aug. 2004-May 2006 Graduated in 05/2006

2. Laurence Holmes (MD, MPH) DrPH in Epidemiology (qualifying) Aug. 2004-Jan. 2006 Passed qualifying exam

Laurence Holmes (MD, MPH) DrPH in Epidemiology(dissertation) Jan. 2006-Aug. 2006 Graduated in 08/2006

3. Thanh Q. Tran (MS) PhD in Epidemiology (qualifying) Aug. 2004-Mar. 2007 Passed qualifying exam

4. Amit Habbu (MBBS) MPH in Disease Control Jan. 2005-Jun. 2006 Left for residence training

5. Evette Toney (MPH) PhD in Epidemiology (qualifying) Jan. 2005-Feb. 2006 Passed qualifying exam

6. Judith Wendt (MS) PhD in Epidemiology (qualifying) Jan. 2005-May 2009 Passed qualifying exam

7. Michelle Lacour (BS) MPH in Epidemiology (thesis) Aug. 2005-Nov. 2007 Graduated in 11/2007

8. Ravi Chopra (MD) MS in Epidemiology Aug. 2005-Jun. 2008 Moved away/discontinued

9. Beatrix Foldi (MD) PhD in Epidemiology (qualifying) Aug. 2005-Jul. 2008 Passed qualifying exam

10. Nadia Baramani (MD) MS in Epidemiology (thesis) Aug. 2005-Nov. 2008 Graduated in 11/2008

11. Emily Bettis (BS) MPH in Epidemiology (thesis) Jan. 2006-Nov. 2008 Graduated in 11/2008

12. Sachin Kamble (MD) MPH in Epidemiology Jan. 2006-Jan. 2010 Moved away/discontinued

13. Christian Gutierrez (MPH) PhD in Epidemiology (qualifying) Jun. 2006-Jun. 2009 Moved away/discontinued

14. Sarah Duong (BS) MPH in Epidemiology Aug. 2006-Jul. 2007 Transferred for MD/MPH

15. David Yang (BS) MPH in Epidemiology (thesis) Aug. 2006-Apr. 2009 Graduated in 04/2009

16. Chung-Yuan Hu (MPH) PhD in Epidemiology (qualifying) Aug. 2006-Feb. 2008 Passed qualifying exam

Chung-Yuan Hu (MPH) PhD in Epidemiology (dissertation) Mar. 2008-Aug. 2010 Graduated in 08/2010

17. Jonas De Souza (MD fellow) MS in Epidemiology Jan. 2007-Jan. 2009 Transferred to U. Chicago

18. Joyce Li (MD fellow) MPH in Epidemiology (thesis) Jan. 2007-Apr. 2009 Graduated in 04/2009

19. Robin A. Lacour (MD fellow) MPH in Epidemiology (thesis) Jul. 2007-Mar. 2008 Graduated in 03/2008

20. Larissa Meyer (MD fellow) MPH in Epidemiology Aug. 2007-Mar. 2008 Changed to genetic epi

21. Rita Sheth (MD fellow) MPH in Epidemiology (thesis) Aug. 2007-Apr. 2009 Graduated in 04/2009

22. Jessica Clague (MS) PhD in Epidemiology (qualifying) Aug. 2007-May 2009 Passed qualifying exam

Jessica Clague (MS) PhD in Epidemiology (dissertation) May 2009-Apr. 2010 Graduated in 04/2010

23. Brady Moffett (PharmD) MPH in Epidemiology (thesis) Jan. 2008-Apr. 2010 Graduated in 04/2010

24. Brian Badgwell (MD fellow) MS in Epidemiology (thesis) Jan. 2008-Aug. 2008 Graduated in 08/2008

25. Arica White (MPH) PhD in Epidemiology (dissertation) Mar. 2008-Aug. 2009 Graduated in 08/2009

26. Zhannat Nurgalieva (MD, MPH) PhD in Epidemiology (qualifying) Aug. 2008-June 2010 Passed qualifying exam

Zhannat Nurgalieva (MD, MPH) PhD in Epidemiology (dissertation) June 2010-Nov. 2012 Graduated in 11/2012

27. Michelle Ludwig (MD, MPH) PhD in Epidemiology (qualifying) Aug. 2008-Aug. 2009 Passed qualifying exam

Michelle Ludwig (MD, MPH) PhD in Epidemiology (dissertation) Aug. 2009-Dec. 2013 Graduated in 12/2013

28. Stephen Gruschkus (MPH) PhD in Epidemiology (dissertation) Oct. 2008-Aug. 2009 Graduated in 08/2009

29. Daniel A. Anaya (MD) MPH in Epidemiology Jan. 2009-Jan. 2012 Moved away/discontinued

30. Peter N. Abotchie (MPH) DrPH in HPBS (dissertation) Jun. 2009-May 2010 Graduated in 05/2010


of 40

31. Ali Mazloom (MD) MPH in Epidemiology Aug. 2009-Aug. 2010 Transferred to another U.

32. Kathryn A. Kimbrough (MD) MPH in Epidemiology (capstone) Aug. 2010-May 2012 Graduated in 05/2012

33. Li Nan (MD) MS in Epidemiology (thesis) Aug. 2010-May 2012 Graduated in 05/2012

34. Laitan O. Lansebe (BS) MPH in Epidemiology (thesis) Aug. 2010-May 2012 Graduated in 05/2012

35. Olaoya, Adeniran A (MD) MPH in Epidemiology (capstone) Oct. 2010-May 2012 Graduated in 05/2012

36. Suman, Saurav (MD) MPH in Epidemiology (capstone) Dec. 2010-Jan. 2014 Graduated in 05/2014

37. Yucel, Emre (BS, MS) PhD in Epidemiology (qualifying) Aug. 2011-Dec. 2011 Changed the program

38. Luis J. Garcia Morales (MD) MS in Epidemiology Jan. 2012-May 2014 Changed the program

39. Alaina J. Brown (MD) MPH in Epidemiology (capstone) Aug. 2012-Jan. 2014 Graduated in 05/2014

40. Mohammad Shakhatreh (MD) MPH in Epidemiology (thesis) Aug. 2012-May 2014 Graduated in 05/2014

41. Tong, Liyue (MS) PhD in Epidemiology (dissertation) Oct. 2012-Jan. 2014 Graduated in 01/2014

42. Poonawalla, Insiya B (MPH) PhD in Epidemiology (dissertation) Dec. 2012-May 2015 Graduated in 05/2015

43. Chen Ying (MS) PhD in Epidemiology (qualifying) Aug. 2013-Jan. 2014 Passed prelim-exam

Chen Ying (MS) PhD in Epidemiology (dissertation) Feb. 2014-Dec. 2016 Graduated in 12/2016

44. Shuangshuang Fu (MS) PhD in Epidemiology (qualifying) Aug. 2013-July 2015 Passed prelim-exam

Shuangshuang Fu (MS) PhD in Epidemiology (dissertation) Aug. 2015-present

45. Xerxes N. Pundole (MD, MPH) PhD in Epidemiology (qualifying) Aug. 2013-July 2014 Passed prelim-exam

Xerxes N. Pundole (MD, MPH) PhD in Epidemiology (dissertation) Aug. 2014-Dec. 2016 Graduated in 12/2016

46. Anand, Grace Shebha (MD) MPH in Epidemiology (capstone) Jan. 2014-May 2017 Graduated in 05/2017

47. Chi Nguyen (MPH) PhD in Epidemiology (dissertation) Jan. 2014-present

48. Xiaotao Zhang (MD, MS) PhD in Epidemiology (qualifying) Aug. 2014-July 2016 Passed prelim-exam

49. Joshua Swan (MS) MPH in Epidemiology (thesis) Aug. 2014-May 2016 Graduated in 05/2016

50. Aylin Tansel (MD) MPH in Epidemiology (thesis) Aug. 2014-Dec. 2016 Graduated in 12/2016

51. Abhinav Dodeja (MD) MPH in Epidemiology Aug. 2014-present

52. Kathy M. Abusager (BS) MPH in Epidemiology (capstone) Feb. 2015-Dec. 2015 Graduated in 12/2015

53. Catherine Hambleton (MD) MPH in Epidemiology (capstone) Aug. 2015-May 2017 Graduated in 05/2017

54. Alexia Wilson (BA) MPH in Epidemiology Jan. 2016-present

55. Christine N. Spencer (MPH) PhD in Epidemiology (dissertation) Jun. 2016-present

56. Ikoma, Naruhiko (MD) MS in Epidemiology (thesis) Aug. 2016-Aug. 2017 Graduated in 08/2017

57. Tam, Samantha (MD) MPH in Epidemiology (thesis) Aug. 2016-present

58. Nair, Mrudula (BDS) MPH in Epidemiology Aug. 2016-present

59. Smith, Robert (BS) MPH in Epidemiology Aug. 2016-present

60. Puja Aggarwal (BDS) PhD in Epidemiology (dissertation) Sep. 2016-present

RESEARCH ACTIVITIES:

I. Major Areas of Research Interest:

Clinical Epidemiology, Epidemiology of Cardiovascular Diseases, Epidemiology of Cancer, Health Services Research,

Outcomes Research, Breast Cancer Outcomes Research, Nationwide Medicare Claims-Based Research, Disease

Registries (cancer and stroke), Patterns of Care Studies, Evaluating the Effectiveness of Health Services and Therapies,

Comparative Effectiveness Research on Health Services/Therapies, Disparities in Healthcare and Outcomes, and

Postmarketing Drug Surveillance of Adverse-Effects or Toxicities.

II. Research Grant Support:

Active Grants:

1. Grant Title: “Impact of Health Insurance on Racial Disparities in Cancer Screening, Diagnosis, Treatment and

Survival in Texas”

PI: Du, Xianglin L. at UT-SPH; Agency: CPRIT (Cancer Prevention and Research Institute of Texas);

Type and Grant Number: Individual Investigator Research Award-RP130051;

Period: 06/01/13 - 11/30/17; Total cost: $435,049; Effort: 25%;

Role: PI.

2. Grant Title: “Graduate Training Program in Breast Cancer Disparities at UTSPH”


of 40

PI: Dr. Sally Vernon at UT-SPH; Agency: Susan J. Komen for the Cure Foundation;

Type: Training grant - GTDR14300827; Period: 10/30/14 - 10/29/17; Total cost: $135,000; Effort: 5.5%.

Role: Co-Investigator and Mentor.

3. Grant Title: “Graduate Training Program in Breast Cancer Disparities at UTSPH”

PI: Dr. Sally Vernon at UT-SPH; Agency: Susan J. Komen for the Cure Foundation;

Type: Training grant - GTDR17497435; Period: 10/30/17 - 10/29/20; Total cost: $135,000; Effort: 5.5%.

Role: Co-Investigator and Mentor.

4. Grant Title: “Advancing Cancer Pharmacoepidemiology Research Through EHRs and Informatics”

PI: Dr. Hua Xu; Type and Grant Number: NIH-NCI 1U24 CA194215-01A1;

Period: 09/01/2016 – 08/31/2021; Total costs: $679,300; Effort: 5%;

Role: Co-Investigator.

5. Grant Title: “Behavioral Science Education Cancer Prevention/Control”

PI: Dr. Mullen, Patricia at UT-School of Public Health; Agency: NIH/NCI;

Type: 2R25-CA057712-21; Period: 09/01/13 - 08/31/18; Total cost: $537,192 per year;

Effort: Serving on advisory board and mentor with no salary support.

Role: Advisory Board Member and Mentor.

6. Grant Title: “Research Training in Gasteroenterology”

PI: Dr. Hashem B. El-Serag at Baylor College of Medicine; Agency: NIH/NIDDK;

Type and Grant Number: 2T32DK083266-06; Total cost: $144,277 per year;

Period: 05/01/15 - 04/31/20; Effort: Serving as mentor with no salary support.

Role: Mentor.

Completed Grants:

7. Grant Title: “Comparative Effectiveness and Cost Effectiveness of Cancer Chemotherapy”

PI: Du, Xianglin L. at UT-SPH; Agency: AHRQ; Type: R01-HS018956-01A1;

Period: 04/01/12 - 01/31/17; Total cost: $880,026; Effort: 25%.

Role: PI.

8. Grant Title: “Postmarketing Surveillance of Toxicities Associated with Cancer Chemotherapy”

PI: Xianglin Du; Agency: AHRQ; Type: R01-HS016743-01;

Period: 04/01/07-03/31/12; Total cost: $979,451; Effort: 30%.

Role: PI.

9. Grant Title: “Evaluation of Chemotherapy Claims for Breast Cancer”

PI: Xianglin Du; Agency: NIH/NCI; Type: R01-CA090626-01;

Period: 03/01/01-02/28/06; Total cost: $704,025. Effort: 30% average per year during the study period.

Role: PI.

10. Grant Title: “Research Supplement for Underrepresented Minorities”

PI: Xianglin Du; Agency: NIH/NCI; Type: R01-CA090626-S1;

Period: 03/01/02-01/31/04; Total cost: $316,394. (Note: This grant was to support Dennie Jones, MD, Associate

Professor of Medicine in the Division of Oncology, Department of Internal Medicine to do clinical epidemiology

and health service research, 50% of his efforts).

Role: PI.

11. Grant Title: “Impact of Axillary Dissection on Clinical Outcomes of Breast Cancer Surgery”

PI: Xianglin Du; Agency: U.S. Department of Defense; Type: DAMD17-99-1-9379;

Period: 06/01/99-06/31/01; Total cost: $83,802. Effort: 20%.

Role: PI.


of 40

12. Grant Title: “Variations in Breast Cancer Treatment and Mortality”

PI: JS Goodwin; Agency: NIH/NCI; Type: R01-CA871773;

Period: 06/01/99-05/31/03; Total cost: $1,129,632. Effort: 40%.

Role: Co-investigator. 13. Grant Title: “Use of Claims Data to Study Quality of Cancer Care”

PI: JS Goodwin; Agency: NIH/NCI; Type: R01;

Period: 12/01/03-11/30/07; Total cost: $792,750. Effort: 50%.

Role: Co-investigator (moved to the UT-Houston one month after the study was funded). 14. Grant Title: “Understanding Disparities in Cervical Cancer Survival”

PI: Ann Coker; Agency: NIH/NCI; Type: R21-CA114330;


Role: Co-investigator. 15. Grant Title: “Southwest Center for Occupational and Environmental Health”

PI: Sarah Felknor (former PI: George Delclos); Agency: CDC; Type: 1T42OH008421-01;

Period: 07/01/05-06/30/10; Total Cost: $1,263,791. Effort: 5%.

Role: Co-investigator. 16. Grant Title: “Evaluating the Utilization of Screening for Hepatocellular Carcinoma”

PI: Dr. Jessica A. Davila; Agency: American Cancer Society; Type: RSGDB-07-010-01-CPHPS;


Role: Co-investigator (PI for subcontract with the Baylor College of Medicine at Houston). 17. Grant Title: “Effective Surveillance Strategies for Melanoma Patients”

PI: Dr. Cormier, Janice at UT-MDACC; Agency: NIH/NCI; Type: R01-CA127328-01A1;

Period: 12/01/07-11/30/10 (NC extension to 11/30/2012); Total cost: $878,508; Effort: 10%.

Role: Co-Investigator (PI for subcontract with the UT-MD Anderson Cancer Center at Houston). 18. Grant Title: “Batterer Psychological Profile--Preventing Partner Abuse”

PI: Ann Coker; Agency: CDC; Type: R49CE000606;

Period: 03/01/08-08/31/09; Total cost: $285,941; Effort: 5.5%.

Role: Co-investigator (PI for subcontract with the University of Kentucky at Lexington). 19. Grant Title: “Finding Vulnerable Populations in the Community and Their Special Needs for Public Health

Emergency Preparedness Using Medicaid and Medicare Data”

PI: Liu, Leanne at the Houston Department of Health and Human Services;

Agency: Texas Department of Health and Human Services and Centers for Disease Control & Prevention;

Type: Public Health Emergency Preparedness Award;

Period: 07/01/10-06/31/11; Total cost: $151,793; Effort: 10%;

Role: Co-Investigator. 20. Grant Title: “Texas Breast Cancer Screening, Early Detection and Treatment Program Outcomes Study”

PI: Dr. Begley, Charles at UT-SPH; Agency: CPRIT (Cancer Prevention and Research Institute of Texas); Type:

Innovation Awards for Cancer Prevention Programs and Services-PP100124;

Period: 08/01/10-01/31/12; Total cost: $138,768; Effort: 10%;

Role: Co-Investigator. 21. Grant Title: “CERCIT: Comparative Effectiveness Research On Cancer in Texas”

PI: Dr. Goodwin, JS at UTMB; Agency: CPRIT (Cancer Prevention and Research Institute of Texas);

Type: Multi-Investigator Award-RP101207; Period: 8/1/10-7/31/13; Total cost: $4,861,175; Effort: 10%;

Role: Co-Investigator (one core project) and Mentor (on training core).


of 40

22. Grant Title: “A Transdisciplinary Training Program for Public Health Researchers and Practitioners Wanting

To Impact Breast Cancer Disparities”

PI: Dr. Luisa Franzini; Agency: Susan J. Komen for the Cure Foundation;

Type: Training grant - KG090010; Period: 08/01/09-07/31/11; Total cost: $337,426; Effort: 5%.

Role: Co-Investigator and Mentor. 23. Grant Title: “A Transdisciplinary Training Program for Public Health Master and Doctoral Students Wanting

to Impact Breast Cancer Disparities”

PI: Dr. Luisa Franzini at UT-SPH; Agency: Susan J. Komen for the Cure Foundation;

Type: Training grant – KG111378; Period: 08/01/11-07/31/13; Total cost: $269,722; Effort: 5%.

Role: Co-Investigator and Mentor. 24. Bridge Funding from UT-SPH:

PI: Du, Xianglin L; Period: 04/01/10-06/30/10; Total cost: $8,097.00;

Description: This bridge funding is to cover 50% of a research associate’s 3-month salary for April 1-June 30,

2010. 25. Grant Title: “East Lancashire Stroke Prevention Project, England”

PI: JK Cruickshank; Agency: East Lancashire Health Authority, England:

Periods: 07/01/93-06/30/95; Total cost: $50,000. Effort: 40%.

Role: Co-investigator. 26. Grant Title: “Health Services Research in Under-Served Populations”

PI: J.L. Freeman; Agency: Agency for Healthcare Research and Quality (AHRQ);

Type: R24-HS11618; Period: 09/30/01-08/31/04; Effort: Core faculty/mentor with no salary support.

Role: Core Faculty and Mentor for post-doc fellows. 27. Grant Title: “NRSA Health of Older Minorities”

PI: J. S. Goodwin; Agency: NIH/NIA; Type: T32-AG00270; Period: 07/01/99-06/30/04.

Effort: Core faculty/mentor with no salary support.

Role: Core Faculty and Mentor for post-doc fellows. 28. Grant Title: “Training of Academic Surgical Oncologists”

PI: Dr. Lee Ellis at UT-MD Anderson Cancer Center; Agency: NIH/NCI;

Type and Grant Number: 5 T32-CA09599-19; Total cost: $525,198 per year;

Period: 2/1/07-1/31/08; Effort: Serving as mentor with no salary support.

Role: Mentor. 29. Grant Title: “Training of Academic Surgical Oncologists”

PI: Dr. Ellis, Lee at UT-MD Anderson Cancer Center; Agency: NIH/NCI;

Type and Grant Number: 2T32-CA009599-20; Total cost: $500,982 per year;

Period: 02/01/08-01/31/13; Effort: Serving as mentor with no salary support.

Role: Mentor. 30. Grant Title: “Behavioral Science Education Cancer Prevention/Control”

PI: Mullen, Patricia at UT-School of Public Health; Agency: NIH/NCI;

Type: 5R25-CA057712-15; Period: 09/01/07-08/31/08; Total cost: $480,910 per year;


Role: Advisory Committee Member and Mentor. 31. Grant Title: “Behavioral Science Education Cancer Prevention/Control”

PI: Dr. Mullen, Patricia at UT-School of Public Health; Agency: NIH/NCI;

Type: 2R25-CA057712-16; Period: 09/01/08-08/31/13; Total cost: $480,910 per year;


of 40


Role: Advisory Board Member and Mentor. 32. Grant Title: “Research Training in Gasteroenterology”

PI: Dr. Hashem B. El-Serag at Baylor College of Medicine; Agency: NIH/NIDDK;

Type and Grant Number: T32DK083266-01; Total cost: $131,970 per year;

Period: 04/01/10 - 03/31/15; Effort: Serving as mentor with no salary support.

Role: Mentor. 33. Grant Title: “Effectiveness of Pegfilgrastim Vs. Filgrastim in Elderly Breast Cancer Patients”

PI: Rajan, Suja at UT-SPH; Agency: NIH/NCI; Type and Grant Number: R03-CA181977-01;

Period: 01/01/14 - 12/31/15 (NCE to 12/31/16); Total cost: $152,000; Effort: 5%;

Role: Co-Investigator. 34. Grant Title: “Repurposing Existing Drugs for Cancer Treatment using Electronic Health Records”

PI: Xu, Hua at UT-School of Biomedical Informatics; Agency: CPRIT;

Type and Grant Number: Recruitment of Rising Stars-CPRIT Scholar-R1307;

Period: 03/01/13 - 02/28/16; Total cost: $2,806,000; Effort: 5%;

Role: Co-Investigator.

PUBLICATIONS:

I. Articles Published in Peer-Reviewed Scientific Journals (in chronological order):

1. Du XL. The Status quo and reform of health centres. Journal of Chinese Rural Health Services Administration.

1984;3(4):17-19.

2. Du XL, Zu S, Zhu A. Assessment of activities of daily living in the elderly. Chinese Journal of Gerontology.

1988;8(3):163-166.

3. Du XL, Zhu A, Zu S. Active life expectancy in the elderly. Chinese Journal of Geriatrics. 1989;8(4):231-233.

4. Parker SG, Du XL, Bardsley MJ, Goodfellow J, Cooper RG, Cleary R, Broughton D, Striet C, James OFW. Measuring

outcomes in care of the elderly. Journal of the Royal College of Physicians of London. 1994;28:428-433.

5. Du XL, Cruickshank K, McNamee R, Saraee M, Sourbutts J, Summers A, Roberts N, Walton E, Holmes S. Case-

Control Study of Stroke and the Quality of Hypertension Control in North West England. BMJ. 1997;314:272-276.

6. Du XL, Sourbutts J, Cruickshank K, Summers A, Roberts N, Walton E, Holmes S. A community-based stroke register

in a high risk area for stroke in north west England. Journal of Epidemiology and Community Health. 1997;51:472-478.

7. Du XL, Freeman JL, Goodwin JS. The declining use of axillary dissection in patients with early stage breast cancer.

Breast Cancer Research and Treatment. 1999;53(2):137-144.

8. Du XL, Freeman JL, Goodwin JS. Information on radiation treatment in patients with breast cancer: the advantages of

the linked Medicare and SEER data. Journal of Clinical Epidemiology. 1999;52(5):463-470.

9. Du XL, Freeman JL, Freeman DH, Syblik DA, Goodwin JS. Temporal and regional variation in the use of breast

conserving surgery and radiotherapy for older women with early stage breast cancer from 1983 to 1995. Journal of

Gerontology (Medical Sciences). 1999;54(9):474-478.

10. Du XL. Prevalence, treatment, control and awareness of high blood pressure and the risk of stroke in north west

England. Preventive Medicine. 2000;30(4):288-294.


of 40

11. Du XL, McNamee R, Cruickshank K. Stroke risk from multiple risk factors combined with hypertension: a primary

care based case-control study in a defined population of northwest England. Annals of Epidemiology. 2000;10(6):380-

388.

12. Du XL, Freeman DH, Syblik DA. What drove changes in the use of breast conserving surgery for breast cancer since

the early 1980s? The role of the clinical trial, celebrity action and an NIH consensus statement. Breast Cancer Research

and Treatment. 2000;62(1):71-79.

13. Du XL, Freeman JL, Warren JL, Nattinger AB, Zhang D, Goodwin JS. Accuracy and completeness of Medicare

claims data for surgical treatment of breast cancer. Medical Care. 2000;38(7):719-727.

14. Du XL, Goodwin JS. Patterns of use of chemotherapy for breast cancer in older women: Findings from Medicare

claims data. Journal of Clinical Oncology. 2001;19(5):1455-1461.

15. Du XL, Goodwin JS. Increase of chemotherapy use in older women with breast carcinoma from 1991 to 1996. Cancer.

2001;92(4):730-737. PMCID: PMC2567284 (funded by NCI).

*16. Otiniano ME, Black SA, Ray LA, Du XL, Markides KS. Correlates of diabetic complications in Mexican American

elders. Ethnicity & Disease. 2002;12(2):252-258.

*17. Otiniano ME, Lorimor R, MacDonald E, Du XL. Common fraud experienced by the elderly: Findings from a 1998

survey in Houston, Texas. Texas Medicine. 2002;98(10):46-50.

18. Du XL, Freeman JL, Nattinger AB, Goodwin JS. Survival of women after breast conserving surgery for early stage

breast cancer. Breast Cancer Research and Treatment. 2002;72(1):23-31.

19. Du XL, Osborne C, Goodwin JS. Population-Based Assessment of Hospitalizations for Toxicity from Chemotherapy

in Older Women with Breast Cancer. Journal of Clinical Oncology. 2002;20(24):4636-4642. PMCID: PMC2566741

(funded by NCI).

20. Du XL, Key CR, Osborne C, Mahnken JD, Goodwin JS. Discrepancy between Consensus Recommendations and

Actual Community Use of Adjuvant Chemotherapy in Women with Breast Cancer. Annals of Internal Medicine.


*21. Otiniano ME, Du XL, Ottenbacher K, Black SA, Markides KS. Lower Extremity Amputations in Diabetic Mexican

American Elders: Incidence, Prevalence and Predictive Factors. Journal of Diabetes and Its Complications.

2003;17(2):59-65.

*22. Otiniano ME, Du XL, Ottenbacher K, Markides KS. The Effect of Diabetes Combined with Stroke on Disability,

Self-rated Health and Mortality in Older Mexican Americans: Results from the Hispanic EPESE. Archives of Physical

Medicine and Rehabilitation. 2003;84(5):725-730.

*23. Otiniano ME, Ottenbacher K, Markides KS, Ray LA, Du XL. Self-Reported Heart Attack in Mexican American

Elders: Examination of Incidence, Prevalence, and 7-year Mortality. Journal of the American Geriatrics Society.

2003;51(7):923-929.

*24. Otiniano ME, Markides KS, Ottenbacher K, Ray LA, Du XL. Self-Reported Diabetic Complications and 7-year

Mortality in Mexican American Elders: Findings from a Community-Based Study of Five Southwestern States. Journal of

Diabetes and Its Complications. 2003;17(5):243-248.

25. Du XL, Key CR, Osborne C. Community-Based Assessment of Adjuvant Hormone Therapy in Women with Breast

Cancer, 1991-1997. Breast Journal. 2004;10(5):433-439. PMCID: PMC2566743 (funded by NCI).


of 40

*26. Otiniano ME, Du XL, Maldonado MR, Ray LA, Markides KS. Effect of metabolic syndrome on heart attack and

mortality in Mexican-American elderly persons: findings of 7-year follow-up from the Hispanic established population for

the epidemiological study of the elderly. Journal of Gerontology (Medical Sciences). 2005;60(4):466-70.

27. Osborne C, Ostir GV, Du XL, Peek MK, Goodwin JS. The influence of marital status on the stage at diagnosis,

treatment, and survival of older women with breast cancer. Breast Cancer Research and Treatment. 2005;93(1):41-7.

*28. Cormier JN, *Xing Y, Ding M, Lee J, Mansfield P, Gershenwald J, Ross M, Du XL. Population-Based Assessment

of Surgical Treatment Trends for Patients with Melanoma in the Era of Sentinel Lymph Node Biopsy. Journal of Clinical

Oncology. 2005;23(25):6054-6062.

29. Du XL, Jones DV, Zhang D. Effectiveness of Adjuvant Chemotherapy for Node-Positive Operable Breast Cancer in

Older Women. Journal of Gerontology (Medical Sciences). 2005;60(9):1137-1144. (A guest editorial was invited

specifically for this article). PMCID: PMC2567100 (funded by NCI).

30. Du XL, Chan W, Giordano S, Geraci JM, Delclos GL, Burau K, Fang S. Variation in Modes of Chemotherapy

Administration for Breast Carcinoma and Association with Hospitalization for Chemotherapy-related Toxicity. Cancer.


31. Du XL, Lairson DR, Begley CE, Fang S. Temporal and Geographic Variation in the Use of Hematopoietic Growth

Factors in Older Women Receiving Breast Cancer Chemotherapy: Findings from a Large Population-Based Cohort.

Journal of Clinical Oncology. 2005;23(34):8620-8628. PMCID: PMC2572993 (funded by NCI).

32. Du XL, Key CR, Dickie L, Darling R, Delclos GL, Waller K, Zhang D. Information on Chemotherapy and Hormone

Therapy from Tumor Registry Had Moderate Agreement with Chart Reviews. Journal of Clinical Epidemiology.


33. Du XL, Key CR, Dickie L, Darling R, Geraci JM, Zhang D. External Validation of Medicare Claims for Breast

Cancer Chemotherapy Compared with Medical Chart Reviews. Medical Care. 2006;44(2):124-131. PMCID:

PMC2567101 (funded by NCI).

34. Du XL, Fang S, Coker AL, Sanderson M, Aragaki C, Cormier JN, Xing Y, Gor BJ, Chan W. Racial Disparity and

Socioeconomic Status in Association with Survival in Older Men with Local/Regional Stage Prostate Carcinoma:

Findings From a Large Community-Based Cohort. Cancer. 2006;106(6):1276-1285.

35. Coker AL, Du XL, Fang S, Eggleston K. Socioeconomic Status and Cervical Cancer Survival among Older Women:

Findings from the SEER-Medicare Linked Data Cohorts. Gynecologic Oncology. 2006;102(2):278-284.

36. Sanderson M, Coker AL, Adriana P, Du XL, Peltz G, Fadden MK. A Multilevel Analysis of Socioeconomic Status

and Prostate Cancer Risk. Annals of Epidemiology. 2006;16(12):901-907.

37. Cormier JN, *Xing Y, Ding M, Lee J, Mansfield P, Gershenwald J, Ross M, Du XL. Ethnic Differences among

Patients with Cutaneous Melanoma. Archives of Internal Medicine. 2006;166(17):1907-1914.

38. Du XL, Gor BJ. Racial Disparities and Trends in Radiation Therapy After Breast-Conserving Surgery for Early-Stage

Breast Cancer in Women, 1992 to 2002. Ethnicity & Disease. 2007;17(1):122-128. PMCID: PMC2566852 (funded by

NCI).

*39. Berrios-Rivera JP, Fang S, Cabanillas ME, Cabanillas F, Lu H, Du XL. Variations in Chemotherapy and Radiation

Therapy in a Large Nationwide and Community-Based Cohort of Elderly Patients with Non-Hodgkin’s Lymphoma.

American Journal of Clinical Oncology. 2007;30(2):163-171.

40. Du XL, Meyer TE, Franzini L. Meta-Analysis of Racial Disparities in Survival in Association with Socioeconomic

Status among Men and Women with Colon Cancer. Cancer. 2007;109(11):2161-2170.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16184457&query_hl=7


of 40

*41. Rohatgi N, Du XL, Coker AL, Moye L, Wang M, Fang S. Chemotherapy and Survival for Patients with Multiple

Myeloma: Findings from a Large Nationwide and Population-Based Cohort. American Journal of Clinical Oncology.

2007;30(5):540-548.

*42. Holmes L, Chan W, Jiang Z, Du XL. Effectiveness of Androgen Deprivation Therapy in Prolonging Survival of

Older Men Treated for Locoregional Prostate Cancer. Prostate Cancer & Prostatic Diseases. 2007;10(4):388-95.

43. Du XL, Fang S, Vernon SW, El-Serag H, Shih YT, Davila J, Rasmus M. Racial Disparities and Socioeconomic Status

in Association with Survival in a Large Population-Based Cohort of Elderly Patients with Colon Cancer. Cancer.

2007;110(3):660-669.

*44. Cabanillas ME, Lu H, Fang S, Du XL. Elderly Patients with Non-Hodgkin’s Lymphoma Who Receive

Chemotherapy are at Higher Risk for Osteoporosis and Fractures. Leukemia & Lymphoma. 2007;48(8):1514-21.

45. Du XL, Fox EE, Lai D. Competing Causes of Death for Women with Breast Cancer and Change Over Time From

1975 to 2003. American Journal of Clinical Oncology. 2008;31(2):105-116. PMID: 18391593; PMCID: PMC2570158

(funded by NCI).

46. Du XL, Fang S, Meyer TE. Impact of Treatment and Socioeconomic Status on Racial Disparities in Survival among

Older Women with Breast Cancer. American Journal of Clinical Oncology. 2008;31(2):125-132. PMID: 18391595

(funded by AHRQ).

47. Du XL, Sun CC, Milam MR, Bodurka DC, Fang S. Ethnic Differences in Socioeconomic Status, Diagnosis, Treatment

and Survival Among Older Women with Epithelial Ovarian Cancer. International Journal of Gynecological Cancer.

2008;18(4):660-669. PMID: 17892451 (funded by AHRQ).

**48. Liu L, Coker AL, Du XL, Cormier JN, Ford CE, Fang S. Long-Term Survival after Radical Prostatectomy

Compared to Other Treatments in Older Men with Local or Regional Prostate Cancer. Journal of Surgical Oncology.


49. Zhou Y, Wang H, Romaguera JE, Zhang Y, Fang W, Delasalle KB, Yi LK, Du XL, Wang M. Incidence Trends of

Mantle Cell Lymphoma in the United States between 1992 and 2004. Cancer. 2008:113(4):791-798. PMID: 18615506

(funded by AHRQ).

*50. Wang M, Burau KD, Fang S, Wang H, Du XL. Ethnic Variations in Diagnosis, Treatment, Socioeconomic Status

and Survival in Elderly Patients with Non-Hodgkin’s Lymphoma. Cancer. 2008;113(11):3231-3241. PMID: 18937267

(funded by AHRQ).

*51. White A, Liu CC, Xia R, Burau KD, Cormier JN, Chan W, Du XL. Racial Disparities and Treatment Trends in a

Large Cohort of Elderly African Americans and Caucasians with Colorectal Cancer, 1991 to 2002. Cancer.

2008;113(12):3400-3409. PMID: 18932248 (funded by AHRQ and NCI).

52. Coker AL, Eggleston KS, Du XL, Ramondetta L. Ethnic Disparities in Cervical Cancer Survival among Medicare

Eligible Women in a Multi-Ethnic Population. International Journal of Gynecological Cancer. 2009;19(1):13-20. PMID:

19258935 (funded by NCI).

*53. Hardy D, Liu CC, Xia R, Cormier JN, Chan W, White A, Burau KD, Du XL. Racial Disparities and Treatment

Trends in a Large Cohort of Elderly Black and White Patients with Non-Small Cell Lung Cancer. Cancer.


*54. Taylor LG, Canfield S, Du XL. Review of Major Adverse Effects of Androgen Deprivation Therapy in Men with

Prostate Cancer. Cancer. 2009;115(11):2388-2399. PMID: 19399748 (funded by AHRQ).


of 40

*55. Bhargava A, Du XL. Racial and Socioeconomic Disparities in Adjuvant Chemotherapy for Node-Positive Operable

Breast Cancer in Older Women. Cancer. 2009;115(13):2999-3008. PMID: 19452539 (funded by AHRQ).

*56. Holmes L, Chan W, Jiang Z, Ward D, Essien EJ, Du XL. Impact of Androgen Deprivation Therapy on Racial/Ethnic

Disparities in Survival of Older Men Treated for Locoregional Prostate Cancer. Cancer Control. 2009;16(2):176-185.

PMID: 19337204; PMCID: PMC2664971 (funded by NCI).

*57. Badgwell B, Chang G, Rodriguez-Bigas M, Smith K, Lupo P, Frankowski F, Delclos G, Du XL, Cormier J.

Management and Outcomes of Anorectal Infection in the Cancer Patients. Annals of Surgical Oncology.

2009;16(10):2752-8. PMID: 19649556 (not funded by NIH).

58. Stuff JE, *LaCour M, Du XL, Franklin F, Liu Y, Hughes S, Peters R, Nicklas TA. The Prevalence of Food Insecurity

and Associated Factors among Households with Children in Head Start Programs in Houston, Texas and Birmingham,

Alabama. Race, Gender & Class. 2009;16:31-47. (not funded by NIH).

*59. Nurgalieva Z, Liu CC, Du XL. Risk of Hospitalizations Associated with Adverse-Effects of Chemotherapy in a

Large Community-based Cohort of Elderly Women with Ovarian Cancer. International Journal of Gynecological Cancer.


*60. Hardy D, Xia R, Liu CC, Cormier JN, Nurgalieva Z, Du XL. Racial Disparities and Survival for Non-Small Cell

Lung Cancer in a Large Cohort of Black and White Elderly Patients. Cancer. 2009;115(20):4807-4818. PMID: 19626650

(funded by AHRQ).

61. Du XL, Xia R, Liu CC, Cormier JN, Xing Y, Chan W, Hardy D, Burau KD. Cardiac Toxicity Associated with

Anthracycline-Containing Chemotherapy in Older Women with Breast Cancer. Cancer. 2009;115(22):5296-5308.

[Erratum in: Cancer. 2009;115:5849-51]. PMID: 19672997 (funded by AHRQ).

62. Du XL, Xia R, Hardy D. Relationship between Chemotherapy Use and Cognitive Impairments in Older Women with

Breast Cancer: Findings from a Large Population-Based Cohort. American Journal of Clinical Oncology. 2010;33(6):533-

43. PMID: 20023570 (funded by AHRQ).

*63. Nurgalieva Z, Xia R, Liu CC, Burau KD, Hardy D, Du XL. Risk of Chemotherapy-induced Peripheral Neuropathy in

Large Population-based Cohorts of Elderly Patients with Breast, Ovarian and Lung Cancer. American Journal of

Therapeutics. 2010;17(2):148-158. PMID: 19417586 (funded by AHRQ).

*64. Hardy D, Cormier JN, Xing Y, Liu CC, Xia R, Du XL. Chemotherapy-Associated Toxicity in a Large Cohort of

Patients with Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 2010;5(1):90-98. PMID: 19884853 (funded by

AHRQ).

*65. Guadagnolo BA, Liu CC, Cormier JN, Du XL. Evaluation of Trends in the Use of Intensity Modulated Radiation

Therapy for Head and Neck Cancer from 2000 through 2005: Socioeconomic Disparity and Geographic Variation in a

Large Population based Cohort. Cancer. 2010;116(14):3505-12. PMID: 20564123 (funded by AHRQ).

66. Davila JA, Morgan RO, Richardson PA, Du XL, McGlynn KA, El-Serag HB. Utilization of Screening for

Hepatocellular Carcinoma in the United States. Hepatology. 2010;52(1):132-41. PMID: 20578139; PMCID:

PMC3835698 (funded by American Cancer Society and NIH).

67. Du XL, Liu CC. Racial/Ethnic Disparities in Socioeconomic Status, Diagnosis, Treatment and Survival among

Medicare-insured Men and Women with Head and Neck Cancer. Journal of Health Care for the Poor and Underserved.



of 40

*68. White A, Vernon SW, Franzini L, Du XL. Disparities in Colorectal Cancer Survival: To What Extent Are Racial

Disparities Explained by Differences in Treatment, Tumor or Hospital Characteristics? Cancer. 2010;116(19):4622-31.

PMID: 20626015; PMCID: PMC2946464 (funded by NCI).

*69. Hardy D, Liu CC, Cormier JN, Xia R, Du XL. Cardiac Toxicity in Association with Chemotherapy and Radiation

Therapy in a Large Cohort of Older Patients with Non-Small Cell Lung Cancer. Annals of Oncology. 2010;21(9):1825-

33. PMID: 20211871; PMCID: PMC2980940 (funded by AHRQ).

***70. Lin YF, Lairson DR, Chan W, Du XL, Leung KS, Kennedy-Nasser AA, Gottschalk AM, Bollard CM, Brenner

MK, Krance RA. The Costs and Cost-Effectiveness of Allogeneic Peripheral Blood Stem Cell Transplantation versus

Bone Marrow Transplantation in Pediatric Patients with Acute Leukemia. Biology of Blood and Marrow Transplantation.

2010;16:1272-81. PMID: 20348004; PMCID: PMC2919628 (funded by NIH).

*71. Gruschkus SK, Lairson D, Dunn JK, Risser J, Du XL. Comparative Effectiveness of White Blood Cell Growth

Factors on Neutropenia, Infection, and Survival in Older People with Non-Hodgkin's Lymphoma Treated with

Chemotherapy. Journal of the American Geriatrics Society. 2010;58(10):1885-95. PMID: 20840455 (funded by AHRQ).

*72. Gruschkus SK, Lairson D, Dunn JK, Risser J, Du XL. Use of white blood cell growth factors and risk of acute

myeloid leukemia or myelodysplastic syndrome among elderly patients with non-Hodgkin lymphoma.

Cancer. 2010;116(22):5279-89. PMID: 20665502 (funded by AHRQ).

*73. Gruschkus SK, Lairson D, Dunn JK, Risser J, Du XL. Cost-effectiveness of white blood cell growth factor use

among a large nationwide cohort of elderly non-Hodgkin’s lymphoma patients treated with chemotherapy. Value in

Health. 2011;14(2):253-262. PMID: 21402294 (funded by AHRQ).

***74. Lin YF, Lairson DR, Chan W, Du XL, Heslop HE, Brenner MK, Krance RA. Children with Acute Leukemia: A

Comparison of Outcomes from Allogeneic Blood Stem Cell and Bone Marrow Transplantation. Pediatric Blood and

Cancer. 2011;56(1):143-51. PMID: 21108446 (not funded by NIH).

*75. Liu CC, Xia R, Guadagnolo A, Cormier JN, Du XL. Risk of Xerostomia in Association with the Receipt of

Radiation Therapy in Older Patients with Head and Neck Cancer. American Journal of Therapeutics. 2011;18(3):206-215.

PMID: 20068441 (funded by AHRQ).

*76. Nurgalieva Z, Liu CC, Du XL. Chemotherapy Use and Risk of Bone Marrow Suppression in a Large Population-

Based Cohort of Older Women with Breast and Ovarian Cancer. Medical Oncology. 2011;28(3):716-25. PMID:

20361359 (funded by AHRQ).

*77. Hu CY, Delclos GL, Chan W, Du XL. Assessing the Initiation and Completion of Adjuvant Chemotherapy in a

Large Nationwide and Population-Based Cohort of Elderly Patients with Stage III Colon Cancer. Medical Oncology.


*78. Hu CY, Delclos GL, Chan W, Du XL. Post-Treatment Surveillance in a Large Cohort of Colon Cancer Patients.

American Journal of Managed Care. 2011;17:329-336. PMID: 21718080 (funded by AHRQ).

*79. Cheng L, Eng C, DeJesus Y, Nieman LZ, Kapadia AS, Du XL. Trends in Colorectal Cancer Incidence by Anatomic

Site and Disease Stage in the United States from 1976 to 2005. American Journal of Clinical Oncology. 2011;34(6):573-

80. PMID: 21217399 (funded by AHRQ).

*80. White A, Coker AL, Du XL, Eggleston KS, Williams M. Racial/ethnic disparities in survival among men diagnosed

with prostate cancer in Texas. Cancer. 2011;117(5):1080-1088. PMID: 21351084; PMCID: PMC3100436 (funded by

NIH).


of 40

***81. Hosain MGM, Sanderson M, Du XL, Chan W, Strom S. Racial/ethnic differences in predictors of PSA screening

in a tri-ethnic population. Central European Journal of Public Health. 2011;19:30-34. PMID: 21526653 (not funded by

NIH).

*82. Hardy D, Chan W, Liu CC, Cormier JN, Xia R, Bruera E, Du XL. Racial disparities in the use of hospice services

according to geographic residence and socioeconomic status in an elderly cohort with nonsmall cell lung cancer. Cancer.

2011;117 (7):1506-1515. PMID: 21425152 (funded by AHRQ).

83. *Clague JN, Reynolds P, Sullivan-Halley J, Ma H, Lacey JV, Henderson KD, Ursin G, West DW, Chang S, Delclos

G, Du XL, Forman MR, Bernstein L. Menopausal Hormone Therapy Does not Influence Lung Cancer Risk: Results from

the California Teachers Study. Cancer Epidemiology, Biomarkers & Prevention. 2011;20(3):560-4. PMID: 21266521;

PMCID: PMC3065239 (funded by NCI).

*84. White A, Vernon SW, Franzini L, Du XL. Racial and Ethnic Disparities in Colorectal Cancer Screening Persisted

Despite Expansion of Medicare's Screening Reimbursement. Cancer Epidemiology, Biomarkers & Prevention.

2011;20(5):811-817. PMID: 21546366 (funded by NCI).

85. Du XL, Xia R, Burau K, Liu CC. Cardiac Risk Associated with the Receipt of Anthracycline and Trastuzumab in a

Large Nationwide Cohort of Older Women with Breast Cancer, 1998-2005. Medical Oncology. 2011;28(supplement

1):S80-90. PMID: 20967512 (funded by AHRQ).

86. Du XL, Lin CC, Johnson NJ, Altekruse S. Effects of Individual-Level Socioeconomic Factors on Racial Disparities in

Cancer Treatment and Survival: Findings from the National Longitudinal Mortality Study, 1979-2003. Cancer.

2011;117(14):3242-51. PMID: 21264829; PMCID: PMC3090714 (funded by NCI and Census Burau).

*87. Hardy D, Chan W, Liu CC, Cormier JN, Xia R, Bruera E, Du XL. Racial disparities and length-of-stay in hospice in

an elderly cohort with non-small cell lung cancer. Palliative Medicine. 2012;26(1):61-71. PMID: 21606129 (funded by

AHRQ).

**88. Sail K, Franzini L, Lairson DR, Du XL. Differences in Treatment and Survival among African American and

Caucasian Women with Early Stage Operable Breast Cancer. Ethnicity and Health. 2012;17(3):309-323. PMID:

22066691 (funded by AHRQ and Susan Komen for the Cure).

***89. Sail K, Franzini L, Lairson DR, Du XL. Clinical and Economic Outcomes Associated With Adjuvant

Chemotherapy In Elderly Patients With Early Stage Operable Breast Cancer. Value in Health. 2012;15(1):72-80. PMID:

22264974 (funded by Susan Komen for the Cure Foundation).

*90. Abotchie PN, Vernon SW, Du XL. Gender differences in colorectal cancer incidence in the United States, 1975-

2006. Journal of Women’s Health. 2012;21(4):393-400. PMID: 22149014; PMCID: PMC3321677 (funded by NCI).

*91. Hu CY, Chan W, Delclos G, Du XL. Adjuvant Chemotherapy and Risk of Gastrointestinal, Hematological and

Cardiac Toxicities for Stage III Colon Cancer among Elderly Patients. American Journal of Clinical Oncology.


92. Wang H, Chen Y, Li F, Delasalle K, Wang J, Alexanian A, Kwak L, Rustveld L, Du XL, Wang M. Temporal and

Geographic Variations of Waldenström’s Macroglobulinemia Incidence: A Large Population-Based Study. Cancer.


***93. Hosain MGM, Sanderson M, Du XL, Chan W, Strom S. Racial/ethnic differences in treatment discussed, chosen

and received for prostate cancer in a tri-ethnic population. American Journal of Men's Health. 2012;6(03):249-257.

PMID: 22419652; PMCID: PMC3368001 (funded by NIH).

http://www.ncbi.nlm.nih.gov/pubmed/21425152


http://www.ncbi.nlm.nih.gov/pubmed?term=%22Clague%20JN%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Reynolds%20P%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Sullivan-Halley%20J%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Ma%20H%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Lacey%20JV%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Henderson%20KD%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Ursin%20G%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22West%20DW%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Chang%20S%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Delclos%20G%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Delclos%20G%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Du%20XL%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Forman%20MR%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Bernstein%20L%22%5BAuthor%5D


of 40

94. Cen P, Banki F, Cheng L, Khalil K, Du XL, Fallon MB, Amato R, Kaiser LR. Changes in Age, Stage distribution and

Survival of Patients with Esophageal Adenocarcinoma over Three Decades in the United States. Annals of Surgical

Oncology. 2012;19(5):1685-91. PMID: 22130619 (not funded by NIH).

*95. Cen P, Liu CC, Du XL. Comparison of Toxicity Profiles of Fluorouracil versus Oxaliplatin Regimens in a Large

Population-based Cohort of Older Patients with Colorectal Cancer. Annals of Oncology. 2012;23(6):1503-11. PMID:


***96. Kowalkowski MA, Hart SL, Du XL, Baraniuk S, Latini DM. Cancer Perceptions: Implications from the 2007

Health Information National Trends Survey. Journal of Cancer Survivorship. 2012;6(3):287-95. PMID: 22457218 (not

funded by NIH).

***97. Wendt JK, Symanski E, Du XL. Estimation of Asthma Incidence Among Low-Income Children in Texas: A

Novel Approach Using Medicaid Claims Data. American Journal of Epidemiology. 2012;176(8):744-50. PMID:

23024134; PMCID: PMC3571251 (funded by NIH/NIOSH).

***98. Panchal J, Lairson D, Chan W, Du XL. Geographic Variation and Socio-demographic Disparity in the Utilization

of Oxaliplatin-containing Chemotherapy in Patients with Stage-III Colon Cancer. Clinical Colorectal Cancer.

2013;12(2):113-121. PMID: 23137529 (funded by AHRQ and CPRIT).

*99. Li N, Du XL, Reitzel L, Xu L, Sturgis E. Impact of enhanced detection on the increase in thyroid cancer incidence in

the US: review of incidence trends by socioeconomic status within the Surveillance, Epidemiology, and End Results

registry, 1980-2008. Thyroid. 2013;23(1):103-110. PMID: 23043274; PMCID: PMC3539256 (funded by NIH).

*100. Liu L, Wang H, Chen Y, Liu G, Rustveld L, Du XL. Splenic Marginal Zone Lymphoma: a population-based study

on the incidence and survival in the United States from 2001 to 2008. Leukemia and Lymphoma. 2013;54(7):1380-86.

PMID: 23101590 (not funded by NIH).

*101. Nurgalieva Z, Franzini L, Morgan R, Vernon SW, Liu CC, Du XL. Impact of timing of adjuvant chemotherapy

initiation and completion after surgery on racial disparities in survival among women with breast cancer. Medical

Oncology. 2013;30:419 (pages 1-9). PMID: 23292872 (funded by AHRQ and Komen for the Cure foundation).

***102. Wang GD, Lai DJ, Burau KD, Du XL. Potential gains in life expectancy from reducing heart disease, cancer,

Alzheimer’s disease, kidney disease or HIV/AIDS as major causes of death in the USA. Public Health. 2013;127(4):348-

356. PMID: 23507421 (not funded by NIH).

***103. Cai Y, Lai D, Waller K, Du XL, Burau K, Symanski E. Statistical Analysis of the Day of the Week Effect on

Births in Harris County, Texas. Journal of Biological Systems. 2013;21(2):1350014 (pages 1-8). (not funded by NIH).

104. Du XL, Parikh RC, Lairson DR, Giordano SH, Cen P. Comparative Effectiveness of Platinum-based Chemotherapy

versus Taxane and Other Regimens for Ovarian Cancer. Medical Oncology. 2013;30(1):440 (pages 1-14). PMID:

23307252 (funded by AHRQ & CPRIT).

105. Du XL, Cai Y, Symanski E. Association between Chemotherapy and Cognitive Impairments in a Large Cohort of

Patients with Colorectal Cancer. International Journal of Oncology. 2013;42(6):2123-2133. PMID: 23563930 (funded by

AHRQ & CPRIT).

106. Yi M, Xu J, Liu P, Chang GJ, Du XL, Hu CY, Song Y, He J, Ren Y, Wei Y, Yang J, Hunt KK, Li X.

Comparative analysis of lifestyle factors, screening test use, and clinicopathologic features in association with survival

among Asian Americans with colorectal cancer. British Journal of Cancer. 2013;108:1508-1514. PMID: 23470470;

PMCID: PMC3629437 (funded by NIH).


of 40

*107. Nurgalieva Z, Franzini L, Morgan R, Vernon SW, Du XL. Utilization of lymph node dissection, race/ethnicity and

breast cancer outcomes. American Journal of Managed Care. 2013;19(10):805-810. PMID: 24304159 (funded by AHRQ

and Susan Komen for the Cure).

108. Liu P , Li X, Mittendorf EA, Li J, Du XL, He J, Ren Y, Yang J, Hunt KK, Yi M. Comparison of clinicopathologic

features, and survival in young American women aged 18-39 years in different ethnic groups with breast cancer. British

Journal of Cancer. 2013;109(5):1302-9. PMID: 23907433; PMCID: PMC3778276 (funded by NIH).

*109. Nurgalieva Z, Franzini L, Morgan R, Vernon SW, Du XL. Surveillance mammography use after treatment of

primary breast cancer and racial disparities in survival. Medical Oncology. 2013;30(4):691 (pages 1-8). PMID: 23975632

(funded by AHRQ, Susan Komen for the Cure, and CPRIT).

***110. Tran DT, Gay I, Du XL, Fu Y, Bebermeyer RD, Newmann A, Streckfus C, Chan W, Walji M. Assessing

Periodontitis in Populations: A Systematic Review of the Validity of Partial Mouth Examination Protocols. Journal of

Clinical Periodontology. 2013;40(12):1064-71. PMID: 24192071; PMCID: PMC3859863 (funded by NIH).

***111. Tran DT, Gay I, Du XL, Fu Y, Bebermeyer RD, Newmann A, Streckfus C, Chan W, Walji M. Assessment of

Partial-Mouth Periodontal Examination Protocols for Periodontitis Surveillance. Journal of Clinical Periodontology.

2014;41(9):846-52. PMID: 25041094; PMCID: PMC4318801 (funded by NIH).

***112. Huo J, Lairson DR, Du XL, Chan W, Buchholz TA, Guadagnolo BA. Survival and cost-effectiveness of hospice

care for metastatic melanoma patients. American Journal of Managed Care. 2014;20(5):366-373. PMID: 25181566 (not

funded by NIH).

113. Lairson DR, Parikh RC, Cormier JN, Du XL. Cost-utility analysis of platinum-based chemotherapy versus taxane

and other regimens for ovarian cancer. Value in Health. 2014;17(1):34-42. PMID: 24438715 (funded by AHRQ).

*114. Tong L, Ahn C, Symanski E, Lai D, Du XL. Temporal trends in the leading causes of death among a large national

cohort of patients with colorectal cancer from 1975 to 2009 in the United States. Annals of Epidemiology.


*115. Tong L, Ahn C, Symanski E, Lai D, Du XL. Effects of newly developed chemotherapy regimens, comorbidities,

chemotherapy-related toxicity on the changing patterns of the leading causes of death in elderly patients with colorectal

cancer. Annals of Oncology. 2014;25(6):1234-42. PMID: 24681607; PMCID: PMC4110447 (funded by AHRQ).

*116. Tong L, Ahn C, Symanski E, Lai D, Du XL. Relative impact of earlier diagnosis and improved treatment on

survival for colorectal cancer: A US database study among elderly patients. Cancer Epidemiology. 2014;38(6):733-740.

PMID: 25454261 (funded by AHRQ and CPRIT).

***117. Wendt JK, Symanski E, Stock TH, Chan W, Du XL. Association of Short-Term Increases in Ambient Air

Pollution and Timing of Initial Asthma Diagnosis among Medicaid-Enrolled Children in a Metropolitan Area.

Environmental Research. 2014;131:50-58. PMID: 24657516; PMCID: PMC4502952 (funded by NIH/NIOSH).

*118. Sheth R, Flescher-Peskin M, Du XL. Duration of Hepatitis B Vaccine Immunity in Pediatric Dialysis Patients.

Pediatric Nephrology. 2014;29(10):2029-37. PMID: 24839216 (not funded by NIH).

119. Lairson DR, Parikh RC, Cormier JN, Chan W, Du XL. Cost-Utility Analysis of Chemotherapy Regimens in Elderly

Patients with Stage III Colon Cancer. PharmacoEconomics. 2014;32(10):1005-13. PMID: 24920195 (funded by AHRQ

and CPRIT).

***120. Kowalkowski MA, Mims MA, Day RS, Du XL, Chan W, Chiao EY. Longer duration of combination

antiretroviral therapy reduces the risk of Hodgkin lymphoma: A cohort study of HIV-infected male veterans. Cancer

Epidemiology. 2014;38(4):386-92. PMID: 24947588; PMCID: PMC4447432 (funded by NIH).




of 40

***121. Kowalkowski MA, Day RS, Du XL, Chan W, Chiao E. Cumulative HIV viremia and non-AIDS-defining

malignancies among a sample of HIV-infected male veterans. Journal of Acquired Immune Deficiency Syndromes.

2014;67(2):204-11. PMID: 25078536; PMCID: PMC4162758 (funded by NIH).

*122. Clague J, Reynolds P, Henderson KD, Sullivan-Halley J, Ma H, Lacey JV Jr, Chang S, Delclos GL, Du XL,

Forman MR, Bernstein L. Menopausal Hormone Therapy and Lung Cancer-Specific Mortality Following Diagnosis: The

California Teachers Study. PLoS One. 2014;9(7):e103735. PMID: 25079077; PMCID: PMC4117568 (funded by NIH).

*123. Zhang Y, Fu S, Du XL. Increasing Utilization and Predictors of Hematopoietic Growth Factors in Patients

Diagnosed with Colorectal Cancer: Findings From a Large National Population-based Cohort in the United States, 1992-

2009. Medical Oncology. 2014;31(10):242 (pages 1-11). PMID: 25231751 (funded by AHRQ and CPRIT).

***124. Russell HV, Okcu MF, Kamdar K, Shah MD, Kim E, Swint JM, Chan W, Du XL, Franzini L, Ho V. Algorithm

for analysis of administrative pediatric cancer hospitalization data according to indication for admission. BMC Medical

Informatics and Decision Making. 2014;14(1):88. PMID: 25274165; PMCID: PMC4197316 (funded by CPRIT training

grant).

125. Ren Y, Black DM, Mittendorf EA, Liu P, Li X, Du XL, He J, Yang J, Hunt KK, Yi M. Crossover Effects of

Estrogen Receptor Status on Breast Cancer-Specific Hazard Rates by Age and Race. PLoS One. 2014 Oct

21;9(10):e110281. PMID: 25333877; PMCID: PMC4204865 (funded by NIH).

***126. Kadakia A, Rajan SS, Abughosh S, Du XL, Johnson ML. CMF-regimen preferred as first-course chemotherapy

for older and sicker women with breast cancer: Findings from a SEER-Medicare based population study. American

Journal of Clinical Oncology. 2015;38(2):165-173. PMID: 23608830 (not funded by NIH).

***127. Huo J, Du XL, Lairson DR, Chan WY, Jiang J, Buchholz TA, Guadagnolo BA. Utilization of Surgery,

Chemotherapy, Radiation Therapy, and Hospice at the End of Life for Patients Diagnosed with Metastatic Melanoma.

American Journal of Clinical Oncology. 2015;38(3):235-41. PMID: 23648436; PMCID: PMC3796177 (funded by NIH).

*128. Liu Z, Zhang Y, Franzini L, Cormier JN, Chan W, Xu H, Du XL. Trends and Variations in Breast and Colorectal

Cancer Incidence from 1995 to 2011: A Comparative Study between the Texas Cancer Registry and National Cancer

Institute’s Surveillance, Epidemiology and End Results Data. International Journal of Oncology. 2015;46(4):1819-1826.

PMID: 25672365; PMCID: PMC4356494 (funded by CPRIT).

129. Du XL, Zhang Y, Parikh RC, Lairson DR, Cai Y. Comparative Effectiveness of Chemotherapy Regimens in

Prolonging Survival for Two Large Population-based Cohorts of Elderly Adults with Breast and Colon Cancer in 1992-

2009. Journal of the American Geriatrics Society. 2015;63(8):1570-82. PMID: 26200214 (funded by AHRQ & CPRIT).

*130. Poonawalla IB, Lairson DR, Chan W, Piller LB, Du XL. Cost-Effectiveness of Neoadjuvant Chemotherapy versus

Primary Surgery in Elderly Patients with Advanced Ovarian Cancer. Value in Health. 2015;18(4):387-395. PMID:


*131. Ludwig MS, Kuban DA, Du XL, Lopez DS, Yamal JM, Strom SS. The Role of Androgen Deprivation Therapy on

Biochemical Failure and Distant Metastasis in Intermediate-Risk Prostate Cancer: A Retrospective Study of the Effects of

Radiation Dose Escalation. BMC Cancer. 2015;15(1):190. PMID: 25885406; PMCID: PMC4472156 (funded by NIH).

*132. Wang X, Du XL. Socio-demographic and Geographic Variations in the Utilization of Hormone Therapy in Older

Women with Breast Cancer after Medicare Part-D Coverage. Medical Oncology. 2015;32(5):154 (pages 1-14). PMID:

25837434 (funded by AHRQ and CPRIT).

133. Lairson DR, Parikh RC, Cormier JN, Chan W, Du XL. Cost-Utility Analysis of Treatments for Advanced Non-Small

Cell Lung Cancer. American Journal of Pharmacy Benefits. 2015;7(6):271-279. (funded by AHRQ and CPRIT).




of 40

*134. Zhang Y, Franzini L, Chan W, Xu H, Du XL. Effects of Health Insurance on Tumor Stage, Treatment, and Survival

in Large Cohorts of Patients with Breast and Colorectal Cancer. Journal of Health Care for the Poor and Underserved.

2015;26(4):1336-58. PMID: 26548682 (funded by CPRIT).

*135. Poonawalla IB, Parikh RC, Du XL, VonVille HM, Lairson DR. Cost-Effectiveness of Chemotherapeutic Agents

and Targeted Biologics in Ovarian Cancer: A Systematic Review. PharmacoEconomics. 2015;33(11):1155-85. (Invited

systematic review). PMID: 26072142 (funded by AHRQ).

136. Du XL, Zhang Y. Risks of Venous Thromboembolism, Stroke, Heart Disease and Myelodysplastic Syndrome

Associated with Hematopoietic Growth Factors in a Large Population-based Cohort of Patients with Colorectal Cancer.

Clinical Colorectal Cancer. 2015;14(4):e21-31. PMID: 26119923 (funded by AHRQ and CPRIT).

137. Lairson DR, Parikh RC, Cormier JN, Chan W, Du XL. Cost-Effectiveness of Chemotherapy for Breast Cancer and

Age Effect in Older Women. Value in Health. 2015;18(8):1070-78. PMID: 26686793 (funded by AHRQ and CPRIT).

***138. Park M, Lai D, Du XL, Delclos GP, Moye LA. General Linear Models in a Missing Outcome Environment of

Clinical Trials Incorporating with Splines for Time-Invariant Continuous Adjustment. American Journal of Biostatistics.

2015;5(1):7-51. DOI: 10.3844/amjbsp.2015.7.51. (not funded by NIH).

139. Du XL, Parikh RC, Lairson DR. Racial and Geographic Disparities in the Patterns of Care and Costs at the End of

Life for Patients with Lung Cancer in 2007-2010 after the 2006 Introduction of Bevacizumab. Lung Cancer.

2015;90(3):442-250. PMID: 26439736 (funded by AHRQ and CPRIT).

140. Du XL, Zhang Y, Hardy D. Temporal and Geographic Variations in the Receipt of Colony-Stimulating Factors and

Erythropoiesis-Stimulating Agents in a Large Retrospective Cohort of Older Women with Breast Cancer from 2000 to

2009. American Journal of Therapeutics. 2016;23(2):e411-e421. PMID: 25756469 (funded by AHRQ and CPRIT).

*141. Poonawalla IB, Piller LB, Lairson DR, Chan W, Du XL. Impact of Hematopoietic Growth Factors on Blood

Transfusion Needs, Incidence of Neutropenia and Overall Survival among Elderly Advanced Ovarian Cancer Patients

Treated With Chemotherapy. International Journal of Gynecological Cancer. 2016;26(1):95-103. PMID: 26509851

(funded by AHRQ).

***142. Parikh RC, Du XL, Morgan RO, Lairson DR. Patterns of Treatment Sequences in Chemotherapy and Targeted

Biologics for Metastatic Colorectal Cancer: Findings from a Large Community-based Cohort of Elderly Patients. Drugs

Real World Outcomes. 2016;3(1):69-82. PMID: 27073759; PMCID: PMC4819481 (funded by AHRQ and CPRIT).

**143. Panchal J, Lairson D, Chan W, Du XL. Geographic Variation in Oxaliplatin-Chemotherapy and Survival in Colon

Cancer Patients. American Journal of Therapeutics. 2016;23(3):e720-9. PMID: 24368611 (funded by AHRQ).

***144. Huo J, Lairson DR, Du XL, Chan W, Jiang J, Buchholz TA, Guadagnolo BA. Hospital Case Volume is

Associated With Improved Survival for Patients With Metastatic Melanoma. American Journal of Clinical Oncology.


*145. Farias AJ, Du XL. Ethnic differences in initiation and timing of adjuvant endocrine therapy among older women

with hormone receptor-positive breast cancer enrolled in Medicare Part D. Medical Oncology. 2016;33(2):19 (pages 1-

14). PMID: 26786154; PMCID: PMC4934890 (funded by NCI, AHRQ and CPRIT).

***146. Tran DT, Gay I, Du XL, Fu Y, Bebermeyer RD, Newmann A, Streckfus C, Chan W, Walji M. Partial-mouth

periodontal examination protocol for estimating periodontitis extent and severity in a United States population. Clinical

and Experimental Dental Research. 2016;2(1):73-79. DOI: 10.1002/cre2.24. (not funded by NIH).

147. Du XL, Zhang Y, Hardy D. Associations between Hematopoietic Growth Factors and Risks of Venous

Thromboembolism, Stroke, Heart Disease and Myelodysplastic Syndrome: Findings from a Large Population-based


of 40

Cohort of Women with Breast Cancer. Cancer Causes and Control. 2016;27(5):695-707. PMID: 27059219 (funded by

AHRQ and CPRIT).

*148. Liu Z, Zhang K, Du XL. Risks of Developing Breast and Colorectal Cancer in Association with Incomes and

Geographic Locations in Texas: a Retrospective Cohort Study. BMC Cancer. 2016;16(1):294. doi: 10.1186/s12885-016-

2324-z.. PMID: 27118258; PMCID: PMC4847204 (funded by CPRIT and AHRQ).

149. Li D, Du XL, Ren Y, Liu P, Li S, Yang J, Lv M, Chen L, Wang X, Li E, Yang J, Yi M. Comparative Analysis of

Clinicopathologic Features of, Treatment in, and Survival of Americans with Lung or Bronchial Cancer. PLoS One. 2016

May 31;11(5):e0156617. PMID: 27244238; PMCID: PMC4886968 (not funded by NIH).

*150. Poonawalla IB, Piller LB, Lairson DR, Chan W, Du XL. Use of Hematopoietic Growth Factors and Risk of

Thromboembolic and Pulmonary Toxicities in Elderly Patients with Advanced Ovarian Cancer. Women's Health Issues.


151. Yang J, Du XL, Li ST, Wang BY, Wu YY, Chen ZL, Lv M, Shen YW, Wang X, Dong DF, Li D, Wang F, Li EX, Yi

M, Yang J. Characteristics of Differently Located Colorectal Cancers Support Proximal and Distal Classification: A

Population-Based Study of 57,847 Patients. PLoS One. 2016 Dec 9;11(12):e0167540. PMID: 27936129; PMCID:

PMC5144913 (not funded by NIH).

*152. Ludwig MS, Kuban DA, Strom SS, Du XL, Lopez DS, Yamal JM. Assessing the Optimum use of Androgen-

Deprivation Therapy in High Risk Prostate Cancer Patients Undergoing External Beam Radiation Therapy. American

Journal of Men's Health. 2017;11(1):73–81. PMID: 25891393 (not funded by NIH).

*153. Rajan SS, Cai Y, Yi M, Tsai CL, Du XL. Use of Hematopoietic Growth Factors in Elderly Lung Cancer Patients

Receiving Chemotherapy: A SEER-Medicare Based Study. American Journal of Clinical Oncology. 2017;40(1):66-74.

PMID: 25068470 (funded by AHRQ).

***154. Parikh RC, Du XL, Morgan RO, Lairson DR. Cost Effectiveness of Treatment Sequences of Chemotherapies and

Targeted Biologics for Elderly Metastatic Colorectal Cancer Patients. Journal of Managed Care and Specialty Pharmacy.

2017 Jan;23(1):64-73. PMID: 28025930 (funded by AHRQ and CPRIT).

*155. Farias AJ, Du XL. The association between out-of-pocket costs, race/ethnicity, and adjuvant endocrine therapy

adherence among Medicare patients with breast cancer. Journal of Clinical Oncology. 2017 Jan;35(1):86-95. PMID:

28034069; PMCID: PMC5455689 (funded by NCI, AHRQ and CPRIT).

156. Zhu P, Du XL, Lu G, Zhu JJ. Survival Benefit of Glioblastoma Patients after FDA Approval of Temozolomide

Concomitant with Radiation and Bevacizumab: A Population-Based Study. Oncotarget. 2017 Jul 4;8(27):44015-44031.

doi: 10.18632/oncotarget.17054. PMID: 28467795 (not funded by NIH).

157. Chen Z, Ren Y, Du XL, Yang J, Shen Y, Li S, Wu Y, Lv M, Dong D, Li E, Li W, Liu PJ, Yang J, Yi M. Incidence

and Survival Differences in Esophageal Cancer among Ethnic Groups in the United States. Oncotarget. 2017 Jul

18;8(29):47037-47051. doi: 10.18632/oncotarget.16694. PMID: 28410201 (not funded by NIH).

*158. Chen Y, Lairson DR, Chan W, Huo J, Du XL. Cost-effectiveness of novel agents in multiple myeloma from a US

payer’s perspective. Journal of Managed Care and Specialty Pharmacy. 2017 Aug;23(8):831-843. PMID: 28737990

(funded by AHRQ and CPRIT).

*159. Farias AJ, Du XL. Racial differences in adjuvant endocrine therapy use and discontinuation in association with

mortality among Medicare breast cancer patients by receptor status. Cancer Epidemiology, Biomarkers and Prevention.

2017 Aug;26(8):1266-75. PMID: 28515111; PMCID: PMC5540737 (funded by NCI, AHRQ and CPRIT).



https://www.ncbi.nlm.nih.gov/pubmed/27936129

https://www.ncbi.nlm.nih.gov/pubmed/27936129


of 40

*160. Chen Y, Lairson DR, Chan W, Du XL. Improved survival in Medicare patients with multiple myeloma: findings

from a large nationwide and population-based cohort. Medical Oncology. 2017 Sep;34(9):153. doi: 10.1007/s12032-017-

1001-7. PMID: 28776319 (funded by AHRQ and CPRIT).

*161. Fu S, Wang M, Lairson DR, Li R, Zhao B, Du XL. Trends and variations in mantle cell lymphoma incidence from

1995 to 2013: A comparative study between Texas and National SEER areas. Oncotarget. 2017;In press. PMID: (not

funded by NIH).

162. Zhao H, Zhang N, Ho V, Ding M, He W, Niu J, Yang M, Du XL, Zorzi D, Chavez-MacGregor M, Giordano SH.

Adherence to treatment guidelines and survival for older patients with stage II or III colon cancer in Texas from 2001 to

2011. Cancer. 2017;In press. PMID: (funded by CPRIT).

(Note: Of the 162 peer-reviewed articles, 158 were original articles and 4 (#40, 54, 110 & 135) were review articles.

*First author of the article was student or fellow or junior faculty whom I supervised/advised and I served as

corresponding author for the majority of these articles.

**First author of the article was student and I served on the committee and served as corresponding author.

***First author of the article was student and I served as the thesis/dissertation committee member.)

II. Research Letters, Editorial or Commentary Published in Scientific Journals or Professional Websites:

163. Du XL. Increase in the Use of Breast-Conserving Surgery. JAMA. 1999;282(4):326-327. PMID: PM10432025

(funded by NCI).

164. Du XL. Re: Trends in Use of Adjuvant Multi-Agent Chemotherapy and Tamoxifen for Breast Cancer in the

United States: 1975-1999. Journal of the National Cancer Institute. 2003;95:683-5. PMID: PM12734321 (funded

by NCI).

165. Du XL, Key CR. Chemotherapy in Women with Breast Cancer. Annals of Internal Medicine. 2003;139(10):868-

869. (funded by NCI).

166. Du XL. Enhance the FDA’s Postmarketing Drug Surveillance System of Adverse Effects through the Electronic

Healthcare Data. Epidemiology: Open Access. 2012;2(2):e104:1-3. doi:10.4172/2161-1165.1000e104. (Editorial)

(funded by AHRQ).

167. Du XL. Invited Commentary: “Socioeconomic Disparities in Diffuse Large B-Cell Lymphoma Outcomes”.

Expert Comment at http://www.practiceupdate.com/journalscan/9157. April 04, 2014.

168. Tong L, Du XL. Temporal trend in the diabetes-specific death rate among patients with colorectal cancer from

1975 to 2009 in the United States. Annals of Epidemiology. 2014;24(10):790. (Letter to the Editor) PMID:


III. Abstracts Published in Scientific Journals or Professional Websites:

169. Du XL, Zhu A, Zu S. Multidimensional assessment of health care in the elderly. Proceedings of Postgraduate

Dissertations of Anhui Medical University. 1987;6:52-53.

170. Du XL. A five year retrospective study on cancer mortality in Anhui. Acta Anhui Medical University.

1987;22(1):4-5

171. Du XL, Zhu A, Zu S. Comprehensive evaluation of health status and functional well-being in the elderly. Acta

Anhui Medical University. 1988;23(2):146.

172. Du XL, Zhu A, Zu S. Comparative study on life expectancy and active life expectancy. Acta Anhui Medical

University. 1990;25(1):5.

173. Du XL, Bardsley M, Goodfellow J, Streit C, Cooper R, Broughton D, James OFW, Parker SG. Routine outcomes

assessment on a geriatric rehabilitation unit. Age & Ageing. 1992;21(suppl 2):7.

http://www.practiceupdate.com/journalscan/9157


of 40

174. Streit C, Parker SG, Du XL, Bardsley M, Goodfellow J, James OFW. Long term outcomes after admission to a

geriatric rehabilitation unit. Age & Ageing. 1993; 22(suppl 2):16-17.

175. Parker SG, Du XL, Goodfellow J, Broughton D, Cleary R, James OFW. Measuring outcomes assessment in

elderly patients in a geriatric day hospital. Age & Ageing. 1993;22(suppl 3):5.

176. Cruickshank JK, Du XL, Redmond P. Poorly managed hypertension in diabetes: the postural drop problem, and

potential for preventing premature stroke and coronary events. Diabetic Medicine. 1995;12 (suppl 2):S41.

177. Du XL, Cruickshank JK, Sourbutts J, Summers A, Roberts N, Walton E, Holmes S, Saraee M, Theodoulidis B.

Prevalence, treatment, control and awareness of high blood pressure among first-ever stroke patients in

Northwest England. Journal of Hypertension. 1996;14(suppl 1):S244.

178. Du XL, Cruickshank JK, McNamee R, Summers A. How far can stroke in routine general practice be prevented?

A case-control study in relation to quality of control of blood pressure in East Lancashire. Journal of

Epidemiology and Community Health. 1996;50:583.

179. Du XL, Cruickshank JK, McNamee R, Summers A. How closely is the risk of stroke related to quality of

hypertension detection and control? A case-control study in East Lancashire. Journal of Hypertension.

1996;14:1503-04.

180. Du XL, Cruickshank K, Sourbutts J, Summers A, Roberts N, Walton E and Holmes S. A population’s treatment,

control and awareness of hypertension in relation to stroke risk in northwest England. Annals of Epidemiology.

1998;8:469.

181. Du XL, Freeman JL, Goodwin JS. Information on radiation treatment in patients with breast cancer: the

advantages of the linked Medicare and SEER data. Annals Epidemiology. 1998;8:469.

182. Du XL, McNamee R, Cruickshank K. Stroke risk from multiple risk factors combined with hypertension: a

primary care based case-control study in a defined population of northwest England. American Journal of

Epidemiology. 2000;151(suppl):S36.

183. Du XL, Freeman JL, Nattinger AB, Goodwin JS. The effect of axillary node dissection on survival in women

with early stage breast cancer. Am J Epidemiology. 2000;151(suppl):253.

184. Du XL, Goodwin JS. Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare

claims data. Gerontologist. 2000;40(Special Issue I):344-345.

185. Du XL, Goodwin JS. Increase of Chemotherapy Use in Older Women with Breast Cancer from 1991 to 1996.

Am J Epidemiology. 2001;153(suppl):362.

186. Du XL, Goodwin JS. Using Medicare Data to Examine the Patterns of Chemotherapy Use for Older Women with

Breast Cancer. Am J Epidemiology. 2001;153(suppl):836.

187. Otiniano ME, Du XL, Ray LA, Markides KS. The effect of diabetes combined with stroke on physical

impairment and mortality in elderly Hispanics. Gerontologist. 2001;41(Issue I):249.

188. Du XL, Goodwin JS. Increase of chemotherapy use in older women with breast cancer from 1991 to 1996.

Gerontologist. 2001;41(Special Issue I):337.

189. Otiniano ME, Du XL, Ottenbacher K, Black SA, Markides KS. Lower Extremity Amputations in Diabetic

Mexican American Elders: Incidence, Prevalence and Predictive Factors. Journal of the American Geriatrics

Society. 2002;50(4, supplement):S68.

190. Otiniano ME, Du XL, Ottenbacher K, Markides KS. The Effect of Diabetes Combined with Stroke on Disability,

Self-rated Health and Mortality in Older Mexican Americans: Results from the Hispanic EPESE. J Am Geriatric

Society. 2002;50(4, supplement):S69.

191. Otiniano ME, Du XL, Ottenbacher K, Black SA, Markides KS. Lower Extremity Amputations in Diabetic

Mexican American Elders: Incidence, Prevalence and Predictive Factors. Diabetes. 2002;51(supplement 2):A18.

192. Otiniano ME, Du XL, Ottenbacher K, Markides KS. The Effect of Diabetes Combined with Stroke on Disability,

Self-rated Health and Mortality in Older Mexican Americans: Results from the Hispanic EPESE. Diabetes.

2002;51(supplement 2):A235.

193. Otiniano ME, Du XL, Ray LA, Ottenbacher K, Markides KS. Heart Attack in Mexican American Elders:

Examination of Incidence, Prevalence, and 7-year Mortality. Gerontologist. 2002;42(Special Issue I):300.

194. Du XL, Key CR, Osborne C, Mahnken JD, Goodwin JS. Discrepancy between Consensus Recommendations and

Actual Community Use of Chemotherapy in Women with Breast Cancer. Gerontologist. 2002;42(Special Issue

I):190-191.

195. Otiniano ME, Markides KS, Ottenbacher K, Ray LA, Du XL. Self-Reported Diabetic Complications and 7-year

Mortality in Mexican American Elders: Findings from a Community-Based Study of Five Southwestern States. J

Am Geriatrics Society. 2003;51(4, supplement):S56.


of 40

196. Du XL, Jones D, Goodwin J. Evidence of real-world effectiveness of adjuvant chemotherapy for node-positive

operable breast cancer in old women. Am J Epidemiology. 2003;157(suppl):148.

197. Du XL, Jones DV. Efficacy and effectiveness of adjuvant chemotherapy in old women with node-positive

operable breast cancer. Gerontologist. 2003;43(Special Issue I):141.

198. Cormier JN, Xing Y, Ding M, Ross M, Lee J, Mansfield P, Gershenwald J, Du XL. Population based assessment

of surgical treatment trends for melanoma patients. J Clin Oncol (Meeting Abstracts) 2005;23(June

supplement):7509.

199. Otiniano ME, Ray L, Du XL, Eschbach K, Markides K, Wong R. Migration and Diabetes Control in adult

Mexican men. Journal of the American Geriatrics Society. 2006;54(S4):C43.

200. Du XL, Fang S, Coker AL, Sanderson M, Aragaki C, Cormier JN, Xing Y, Gor BJ, Chan W. Racial Disparities

and Socioeconomic Status in Association with Survival in Older Men with Local/Regional Stage Prostate

Cancer. AcademyHealth Annual Meeting, June 25-27, 2006, Seattle, WA:

http://www.academyhealth.org/arm/awards/abstracts.htm.

201. Hosain M, Sanderson M, Du XL, Chan W, Strom S. Racial/Ethnic differences in prostate cancer screening

between Caucasians and Hispanics. 98th American Association for Cancer Research annual meeting, Apr 14-18,

2007; Los Angeles, CA, http://www.aacrmeetingabstracts.org/content/vol2007/1_Annual_Meeting/index.dtl.

202. Zhou Y, Wang H, Zhang Y, Du X, Kwak L, Romaguera J, Wang M. Trend and geographic variations in the

incidence of mantle cell lymphoma in the United States from 1975 to 2003. Proc ASCO. 2007;25(18S):8091.

203. Zhou Y, Wang H, Zhang Y, Du XL, Romaguera J, Wang M. Trend and Geographic Variations in the Incidence

of Mantle Cell Lymphoma in the United States from 1975 to 2003. ASCO Annual meeting, 2007, #9091:

http://www.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts.

204. Wang M, Zhou Y, Wang H, Yi Q, Zhang Y, Alexanian R, Kwak L, Du X. Trend and geographic variations in the

incidence of Waldenstrom’s Macroglobulinemia in the United States over 17 years from 1988 to 2004.

American Society of Hematology, 49th Annual Meeting, 2007, http://www.abstracts2view.com/hem07/.

205. Zhou Y, Wang H, Du X, Yi Q, Zhang Y, Romaguera J, Wang M. Trend and geographic variations in the

incidence of mantle cell lymphoma in the United States over 30 years from 1975 to 2004. American Society of

Hematology, 49th Annual Meeting, 2007, http://www.abstracts2view.com/hem07/.

206. Du XL, Fang S, Meyer TE. Impact of Treatment and Socioeconomic Status on Racial Disparities in Survival

among Older Women with Breast Cancer. AcademyHealth annual meeting, Orlando, FL, June 3-5, 2007,

http://www.academyhealth.org/2007/abstracts/posters.pdf.

207. Rohatgi N, Du XL, Coker AL, Moye L, Wang M, Fang S. Chemotherapy increases survival in patients with

multiple myeloma. Nature Clinical Practice ONCOLOGY. 2008;5(1).

208. White A, Liu CC, Xia R, Burau KD, Cormier JN, Chan W, Du XL. Racial Disparities & Trends in the Receipt of

Standard Therapy for Colorectal Cancer in a Large Cohort of African Americans & Caucasians Aged 65 Years &

Older. AcademyHealth annual meeting, Washington DC, June 8-10, 2008,

http://www.academyhealth.org/2008/posterabstracts.pdf.

209. Davila JA, Morgan RO, Richardson P, Du XL, McGlynn KA, El-Serag HB. Utilization of Screening for

Hepatocellular Carcinoma in the United States. Digestive Disease Week 2008, San Diego, CA, P-782:

http://download.abstractcentral.com/ddw2008/myddw2008/782.html.

210. Davila JA, Morgan RO, Richardson PA, Du XL, McGlynn KA, El-Serag HB. Physician Characteristics are

Significantly Associated with Screening for Hepatocellular Carcinoma in the United States. International Liver

Cancer Association Annual Conference, Chicago, IL, 2008, P-076: http://www.ilca-

online.org/images/conference_area/pdf/ILCA2008_BookofAbstracts.pdf.

211. Song S, Burau KD, Fang S, Wang H, Du XL, Wang L. Ethnic Variations in Diagnosis, Treatment,

Socioeconomic Status and Survival in a Large Population-Based Cohort of Elderly Patients with Non-Hodgkin’s

Lymphoma.Amercian Society of Hematology 50th Annual Meeting, San Francisco, December 6-9, 2008.

http://ash.confex.com/ash/2008/webprogram/Paper1653.html.

212. Davila JA, Morgan RO, Richardson PA, Du XL, McGlynn KA, El-Serag HB. Outcomes of Screening for

Hepatocellular Carcinoma in the United States. Digestive Disease Week, Chicago, IL, May 30-June 4, 2009, P-

739. http://myddw2009.bdmetrics.com/SOW-26650830/739-Outcomes-of-Screening-for-Hepatocellular-

Carcinoma-in-the-United-States/Overview.aspx.

213. White A, Vernon SW, Franzini L, Du XL. Racial/ethnic disparities and trends in screening for colorectal cancer

among Medicare beneficiaries with cancer and those without cancer in SEER areas, 1992–2002. Cancer Prev Res

2010;3(1 Suppl):B32.

http://www.academyhealth.org/arm/awards/abstracts.htm

http://www.aacrmeetingabstracts.org/content/vol2007/1_Annual_Meeting/index.dtl

http://www.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts

http://www.abstracts2view.com/hem07/

http://www.abstracts2view.com/hem07/

http://www.academyhealth.org/2007/abstracts/posters.pdf

http://www.academyhealth.org/2008/posterabstracts.pdf

http://download.abstractcentral.com/ddw2008/myddw2008/782.html

http://www.ilca-online.org/images/conference_area/pdf/ILCA2008_BookofAbstracts.pdf

http://www.ilca-online.org/images/conference_area/pdf/ILCA2008_BookofAbstracts.pdf

http://ash.confex.com/ash/2008/webprogram/Paper1653.html

http://myddw2009.bdmetrics.com/SOW-26650830/739-Outcomes-of-Screening-for-Hepatocellular-Carcinoma-in-the-United-States/Overview.aspx

http://myddw2009.bdmetrics.com/SOW-26650830/739-Outcomes-of-Screening-for-Hepatocellular-Carcinoma-in-the-United-States/Overview.aspx


of 40

214. Gruschkus SK, Lairson D, Dunn JK, Risser J, Du XL. Use of white blood cell growth factors and risk of acute

myeloid leukemia or myelodysplastic syndrome among elderly non-Hodgkin's lymphoma patients. Cancer Prev

Res 2010;3(1 Suppl):B129.

215. White A, Vernon SW, Franzini L, Du XL. Disparities in Colorectal Cancer Survival: To What Extent Are Racial

Disparities Explained by Differences in Treatment, Tumor or Hospital Characteristics? American Public Health

Association (138th annual meeting in Denver, CO, November 2010) abstracts.

http://apha.confex.com/apha/138am/webprogram/Paper218115.html.

216. Gruschkus SK, Lairson D, Dunn JK, Risser JM, Du XL. Use of white blood cell growth factors and risk of acute

myeloid leukemia or myelodysplastic syndromes among elderly non-Hodgkin's lymphoma patients. Value in

Health. 2010;13(3):page 23 (abstract # PCN1). http://onlinelibrary.wiley.com/doi/10.1111/j.1524-

4733.2010.00722_1.x/pdf.

217. Gruschkus SK, Lairson D, Dunn JK, Risser JM, Du XL. Cost-effectiveness of white blood cell growth factor use

among elderly non-Hodgkin's lymphoma patients treated with chemotherapy. Value in Health. 2010;13(3):page

38 (abstract # PCN76). http://onlinelibrary.wiley.com/doi/10.1111/j.1524-4733.2010.00722_1.x/pdf.

218. Sail K, Franzini L, Du XL, Lairson D. Racial disparities associated with treatment and survival in elderly

patients with early stage operable breast cancer. Value in Health. 2010;13(3):page 48 (abstract # PCN129).

http://onlinelibrary.wiley.com/doi/10.1111/j.1524-4733.2010.00722_1.x/pdf.

219. Sail K, Franzini L, Du XL, Lairson D. Clinical and economic outcomes associated with adjuvant chemotherapy

in elderly patients with early stage operable breast cancer. Value in Health. 2010;13(7):page A262 (abstract #

PCN60). http://download.journals.elsevierhealth.com/pdfs/journals/1098-3015/PIIS1098301511719556.pdf.

220. Panchal J, Lairson D, Chan W, Du XL. Geographic variation and socio-demographic disparity in the utilization

of oxaliplatin-containing chemotherapy in patients with stage-iii colon cancer. Value in Health. 2012;15(4):page

A233 (abstract # PCN138). http://download.journals.elsevierhealth.com/pdfs/journals/1098-

3015/PIIS1098301512013204.pdf.

221. Parikh RC, Lairson DR, Cormier JN, Du XL. Cost-Utility Analysis of Various Chemotherapy Regimens among

Elderly Ovarian Cancer Patients: A Longitudinal Cohort Study. Pharmacoepidemiology and Drug Safety. 2013;

22: (Suppl. 1), page 172 (abstract #356). http://onlinelibrary.wiley.com/doi/10.1002/pds.3512/pdf.

222. Poonawalla IB, Lairson DR, Du XL. Cost assessment of advanced ovarian cancer treatment in a large cohort of

elderly patients. Value in Health. 2014;17(3):A80 (Abstract# PCN72).

http://www.ispor.org/publications/value/VIH_17-3_final.pdf.

223. Lairson DR, Parikh RC, Cormier JN, Chan W, Du XL. Cost-Utility Analysis of Chemotherapy Regimens in

Elderly Patients with Stage III Colon Cancer. Presented at the International Health Economics Association

Conference, July 13-16, 2014, Dublin, Ireland. https://ihea2014.abstractsubmit.org/presentations/11767/.

224. Lairson DR, Parikh RC, Cormier JN, Chan W, Du XL. Cost-Utility Analysis of Chemotherapy and Targeted

Therapy for Advanced Non-Small Cell Lung Cancer in a Large Retrospective Cohort of Elderly Patients.

Presented at the International Health Economics Association (iHEA) Conference, July 12-15, 2015, Milan, Italy.

https://ihea2015.abstractsubmit.org/presentations/13118/.

225. Rajan S, Du XL, Lyman G. Cost Effectiveness of Pegfilgrastim versus Filgrastim in Elderly Breast Cancer

Patients Receiving Chemotherapy. Presented at the International Health Economics Association (iHEA)

Conference, July 12-15, 2015, Milan, Italy. https://ihea2015.abstractsubmit.org/presentations/13343/.

226. Zhang Y, Franzini L, Chan W, Xu H, Du XL. Effects of Health Insurance on Tumor Stage, Treatment, and

Survival in Large Cohorts of Patients with Breast and Colorectal Cancer. Innovations in Cancer Prevention and

Research Conference of the CPRIT, Nov. 9-10, 2015, Austin, Texas: https://s3.amazonaws.com/cprit-

assets/cprit2015/confsite/cprit2015conf_web_v1.pdf, abstract #219, page 128.

227. Liu Z, Zhang Y, Franzini L, Cormier JN, Chan W, Xu H, Du XL. Trends and Variations in Breast and Colorectal

Cancer Incidence from 1995 to 2011: A Comparative Study between Texas and SEER. Innovations in Cancer

Prevention and Research Conference of the CPRIT, Nov. 9-10, 2015, Austin, Texas:

https://s3.amazonaws.com/cprit-assets/cprit2015/confsite/cprit2015conf_web_v1.pdf, abstract #232, page 134.

228. Zhao H, Ding M, Niu J, Ho V, Zhang N, Du XL, Giordano S. Elderly Texas patients’ adherence to treatment

guidelines for regional colorectal cancer. Innovations in Cancer Prevention and Research Conference of the

CPRIT, Nov. 9-10, 2015, Austin, Texas: https://s3.amazonaws.com/cprit-

assets/cprit2015/confsite/cprit2015conf_web_v1.pdf, abstract #384, page 197.

http://apha.confex.com/apha/138am/webprogram/Paper218115.html

http://onlinelibrary.wiley.com/doi/10.1111/j.1524-4733.2010.00722_1.x/pdf




http://download.journals.elsevierhealth.com/pdfs/journals/1098-3015/PIIS1098301511719556.pdf



http://onlinelibrary.wiley.com/doi/10.1002/pds.3512/pdf

http://www.ispor.org/publications/value/VIH_17-3_final.pdf

https://ihea2014.abstractsubmit.org/presentations/11767/



https://s3.amazonaws.com/cprit-assets/cprit2015/confsite/cprit2015conf_web_v1.pdf






of 40

229. Parikh RC, Du XL, Morgan RO, Lairson DR. Treatment patterns among elderly metastatic colorectal cancer

patients - a SEER-Medicare analysis. Presented at ISPOR 20th Annual International Meeting, Philadelphia, PA,

USA, May 16-20, 2015. (abstract # PCN184). https://www.ispor.org/research_study_digest/details.asp.

230. Parikh RC, Du XL, Morgan RO, Lairson DR. Cost Effectiveness of Treatment Sequences for Elderly Metastatic

Colorectal Cancer Patients: A SEER-Medicare-Based Modelling Analysis. Value in Health. 2016;19(3):Page

A150 (abstract # PCN91). http://www.valueinhealthjournal.com/article/S1098-3015(16)01658-2/pdf.

231. Hambleton Davis CM, Shirkey BA, Moore LW, Bailey HR, Du XL, Cusick MV. 52.03 Trends in Utilizing

Laparoscopic Colorectal Surgery Over Time in 2005-2014 Using the NSQIP Database. 2017 Academic Surgical

Congress abstracts. http://www.asc-abstracts.org/abs2017/52-03-trends-in-utilizing-laparoscopic-colorectal-

surgery-over-time-in-2005-2014-using-the-nsqip-database/.

IV. Technical Reports:

232. Du XL. Epidemiology of ageing. Proceedings of Geriatrics of Anhui Gerontology Association. 1986;10-3.

233. Du XL. A cross-sectional study of activities of daily living and active life expectancy in the elderly in two

Counties of Anhui Province. MS Degree Thesis. Anhui, China: Anhui Medical School, 1987.

234. Du XL, Goodfellow J, Broughton D, Cleary R, James OFW, Parker SG. Routine outcomes

measurement in elderly patients in a geriatric day hospital. Newcastle: University of Newcastle

and CASPE Research, 1992.

235. Du XL. A community-based stroke register and case-control study of stroke and the quality of hypertension

control in northwest England. PhD Degree Dissertation. Manchester, England: University of Manchester, 1997.

V. Research presentation awards for projects involving students or post-doctoral fellows whom I advised:

1. Holmes L (DrPH student), Chan W, Jiang Z, Du XL. Influence of Androgen Deprivation Therapy on Racial Disparities

in Survival of Older Men Treated for Locoregional Prostate Cancer. Presented at the 8th Annual Health Services and

Outcomes Research Conference in Houston on November 6, 2007, and won the 1st place award in the Equity research

poster session.

2. White A (PhD student), Liu CC, Xia R, Burau KD, Cormier JN, Chan W, Du XL. Racial Disparities and Treatment

Trends in a Large Cohort of African Americans & Caucasians with Colorectal Cancer, 1991-2002. Presented at the 9th

Annual Health Services and Outcomes Research Conference in Houston on December 3, 2008, and won the 1st place

award in the Equity research poster session.

3. Nurgalieva Z (PhD student), Xia R, Liu CC, Burau KD, Hardy D, Du XL. Chemotherapy-induced Peripheral

Neuropathy in Elderly Patients with Breast, Ovarian or Lung Cancer: Findings from Large Nationwide and Population-

based Cohorts. Presented at the 9th Annual Health Services and Outcomes Research Conference in Houston on December

3, 2008, and won the 1st place award in the Patient Safety research poster session.

4. Sail K (PhD student), Franzini L, Du XL, Lairson DR. Racial Disparities Associated with Treatment and Survival in

Early Stage Operable Breast Cancer Patients. Presented at the 9th Annual Health Services and Outcomes Research

Conference in Houston on December 2, 2009, and won the 2nd place award in the Equity research poster session.

5. Nurgalieva Z (PhD student), Franzini L, Morgan R, Vernon SW, Du XL. Timely Initiation and Completion of

Chemotherapy, Ethnicity And Survival In Breast Cancer Patients. Presented at the 13th Annual Health Services &

Outcomes Research Conference: Improving the Quality of Healthcare Through Accountable Care Organizations and

Technology, on December 13, 2012 in Houston, TX, and won the 1st place award in the 'Timeliness of Care' research

poster session.

6. Poonawalla IB (PhD student), Lairson DR, Chan W, Piller LB, Du XL. Cost assessment of advanced ovarian cancer

treatment in a large cohort of elderly patients. Presented to the 19th International Society for Pharmacoeconomics and

https://www.ispor.org/research_study_digest/details.asp

http://www.valueinhealthjournal.com/article/S1098-3015(16)01658-2/pdf

http://www.asc-abstracts.org/

http://www.asc-abstracts.org/

http://www.asc-abstracts.org/abs2017/52-03-trends-in-utilizing-laparoscopic-colorectal-surgery-over-time-in-2005-2014-using-the-nsqip-database/

http://www.asc-abstracts.org/abs2017/52-03-trends-in-utilizing-laparoscopic-colorectal-surgery-over-time-in-2005-2014-using-the-nsqip-database/


of 40

Outcomes Research (ISPOR) annual meeting on May 31-June 4, 2014 in Montreal, Canada, and received the poster

finalist award to be highlighted at the meeting.

7. Farias AJ (Post-doc fellow), Du XL. Racial/ethnic differences in the use and discontinuation of adjuvant endocrine

therapy by hormone-receptor status in association with mortality among breast cancer patients enrolled in Medicare Part

D. This abstract (#1524) was one of the 16 top-ranked abstracts (out of 183) for 2017 ASPO (American Society of

Preventive Oncology) conference and has been accepted for publication in the journal Cancer Epidemiology, Biomarkers

& Prevention.

8. Farias AJ (Post-doc fellow) received the Calle/Rodriguez Memorial Minority Travel Award by the American Cancer

Society. This award is given to the two top ranking abstracts and each award will cover $1,500 of travel related expenses

to the ASPO 2017 meeting in Seattle, WA. The abstract was: Farias AJ, Du XL. Racial/ethnic differences in the use and

discontinuation of adjuvant endocrine therapy by hormone-receptor status in association with mortality among breast

cancer patients enrolled in Medicare Part D.

VI. Media Reports on Research Findings:

1. In May 2001, the official journal of the American Cancer Society Cancer issued a press release for our article (Du XL,

Goodwin JS. Increase of chemotherapy use in older women with breast carcinoma from 1991 to 1996. Cancer. May 1,

2001;92(4):730-737). The national news magazine Hem/Onc today published a long story entitled “Chemotherapy use

increases in elderly patients” in November 2001 Issue. It was also reported in Internal Medicine News magazine etc.

2. In September 2002, the U.S. Department of Defense Era of Hope National Breast Cancer Program meeting issued a

press release for my research project funded by this program, entitled “Axillary dissection and survival of women after

breast-conserving surgery for early-stage breast cancer”. Several radio news stations and medical news magazines,

including Ivanhoe Broadcast News, Inc., and International Medical News, reported the findings. It was also highlighted in

the UTMB Newsletter Impact on December 16, 2002.

3. In January 2003, the American College of Physicians and Annals of Internal Medicine issued a press release regarding

our article that was published in Annals of Internal Medicine, January 21st issue, 2003 (Du XL, Key CR, Osborne C,

Mahnken JD, Goodwin JS. Discrepancy between consensus recommendations and actual community use of adjuvant

chemotherapy in women with breast cancer. Ann Intern Med. 2003;138:90-97). The UTMB Public Affairs Office also

issued a longer press release regarding this article. The NBC and ABC news, CNN headline news, the New York Times

(January 28, 2003), and TIME Magazine (February 3, 2003) reported the findings.

4. An internationally renowned oncology researcher, Dr. L. Balducci, was invited by the Journal editors for writing an

editorial specifically on our research article published in the September issue of 2005 in the Journal of Gerontology

(Medical Sciences), an official journal of the Gerontologic Society of America. This editorial praised the important

contributions of our research. In his editorial, Dr. Balducci wrote “Du and colleagues have provided an important

contribution to the field by: (a) demonstrating that adjuvant chemotherapy does not have a substantial impact in breast

cancer-related mortality for women aged 70 and older; and (b) providing a demonstration of a very creative use of the

SEER-Medicare database.”

5. In February 2006, the official journal of the American Cancer Society Cancer issued a press release for our article (Du

XL, Fang S, Coker AL, Sanderson M, Aragaki C, Cormier JN, Xing Y, Gor BJ, Chan W. Racial Disparity and

Socioeconomic Status in Association with Survival in Older Men with Local/Regional Stage Prostate Carcinoma:

Findings From a Large Community-Based Cohort. Cancer. Published Online: February 13, 2006. Print Issue Date: March

15, 2006). The widely used wire service HEALTHDAY today and Prostate Cancer Foundation reported the findings

entitled “Poverty Behind Poor Prostate Cancer Outcomes in Black Men” By Meryl Hyman Harris on February 13, 2006.

The findings were also reported in WebMD (2/13/06), medpageTODAY (2/13/06), Urology Times (2/16/06), Patient

Health International (2/20/06), Physician’s Weekly (June 5, 2006), and many other medical professional/foundation

websites.


of 40

6. The abstract entitled “Racial Disparities and Socioeconomic Status in Association with Survival in Older Men with

Local/Regional Stage Prostate Cancer” by Du and colleagues at the UT School of Public Health has been selected for the

best abstracts award (out of 1,646 abstract submissions) at the Annual Conference of the national AcademyHealth on June

25-27, 2006, in Seattle, WA. AcademyHealth is a leading international professional society for advancing research, policy

and practice, and a premier forum for health services research and for Agency for Healthcare Research and Quality

(AHRQ). The detail is available at http://www.academyhealth.org/arm/awards/abstracts.htm. The authors were invited to

present the paper at a special session together with the article of the year.

7. On April 23, 2007, the official journal of the American Cancer Society Cancer issued a press release for our article (Du

XL, Meyer TE, Franzini L. Meta-Analysis of Racial Disparities in Survival in Association with Socioeconomic Status

among Men and Women with Colon Cancer. Cancer. 2007 June 1;109:2161-70). The findings were also reported in

ScienceDaily.com (4/23/07), ASPH (Association of Schools of Public Health) Friday Letter (4/27/07), WebMD, ACS

(American Cancer Society) website, MedicalNewsToday, Science Daily (4/23/07), Scientific American.com (4/24/07),

and Distinctions of the UTHSC-H (July 2007).

8. In October, 2007, our article (Rohatgi N (MS student in epi), Du XL, Coker AL, Moye L, Wang M, Fang S.

Chemotherapy and Survival for Patients with Multiple Myeloma: Findings from a Large Nationwide and Population-

Based Cohort. American Journal of Clinical Oncology. 2007 Oct;30(5):540-548.) was selected by the Nature: Clinical

Practice Oncology for Research Highlights (January 2008 issue), and by the Lancet Oncology for news item.

9. In January 2007, our article “Racial Disparities and Trends in Radiation Therapy After Breast-Conserving Surgery for

Early-Stage Breast Cancer in Women, 1992 to 2002” in Ethnicity & Diseases was selected as a featured article in the

journal and its abstract was selected to be published in New England Journal of Medicine (in the issue of 2007).

10. On July 9, 2008, the official journal of the American Cancer Society Cancer issued a press release for our article

entitled “Incidence Trends of Mantle Cell Lymphoma in the United States Between 1992 and 2004” (Published Online:

July 9, 2008. Print Issue Date: August 15, 2008). The findings were also reported in HealthDay website

(http://www.healthday.com/Article.asp?AID=617214) on July 18, 2008.

11. The August 2008 issue of the newsletter ‘Research Activities’ of the Agency for Healthcare Research and Quality

(AHRQ) published an article entitled “Poorer treatment and lower socioeconomic status may underlie ethnic disparities in

breast cancer survival”, that reported the findings of our study (Du XL, Fang S, Meyer TE. Impact of Treatment and

Socioeconomic Status on Racial Disparities in Survival among Older Women with Breast Cancer. Am J Clin Oncol. April

2008;31:125-132). See weblink: http://ahrq.hhs.gov/research/aug08/0808RA3.htm.

12. The November 2008 issue of the newsletter ‘Research Activities’ of the Agency for Healthcare Research and Quality

(AHRQ) published an article entitled “Less receipt of effective treatment by elderly black women with ovarian cancer

may underlie their poorer survival”, that reported the findings of our study (Du XL, et al. Ethnic Differences in

Socioeconomic Status, Diagnosis, Treatment and Survival Among Older Women with Epithelial Ovarian Cancer.

International Journal of Gynecological Cancer. 2008;18:660-669). See weblink:

http://www.ahrq.gov/research/nov08/1108RA7.htm.

13. The November 2008 issue of the newsletter ‘Research Activities’ of the Agency for Healthcare Research and Quality

(AHRQ) published an article entitled “Prostate removal is better than radiation or watchful waiting for elderly men with

local/regional prostate cancer”, that reported the findings of our study (Liu L, et al. Long-Term Survival after Radical

Prostatectomy Compared to Other Treatments in Older Men with Local or Regional Prostate Cancer. Journal of Surgical

Oncology. 2008;97:583-591). See weblink: http://www.ahrq.gov/research/nov08/1108RA15.htm.

14. On October 20, 2008, the official journal of the American Cancer Society Cancer issued a press release for our article

(Wang M, Burau KD, Fang S, Wang H, Du XL. Ethnic Variations in Diagnosis, Treatment, Socioeconomic Status and

Survival in Elderly Patients with Non-Hodgkin’s Lymphoma. Cancer. Online published October 20, 2008, print issue

December 1, 2008). The findings were reported in websites:

http://www.academyhealth.org/arm/awards/abstracts.htm

http://www.healthday.com/Article.asp?AID=617214

http://ahrq.hhs.gov/research/aug08/

http://ahrq.hhs.gov/research/resact.htm

http://ahrq.hhs.gov/research/aug08/0808RA3.htm



http://www.ahrq.gov/research/nov08/1108RA7.htm





of 40

Medscape Today (10/23/08), Reuters (10/21/08), American Cancer Society (10/20/08), Scientific American (10/21/08),

Science Daily (10/27/08), HealthDay (10/20/08), Medical Breakthroughs (10/21/08), ASCO (10/21/08), UTHSC-H

(10/20/08), and in numerous television websites (10/21/08) (http://us.cisionpoint.com/ListPage.aspx?id=64306815).

15. The February 2009 issue of the newsletter ‘Research Activities’ of the Agency for Healthcare Research and Quality

(AHRQ) published an article entitled “Older white men are most likely to be diagnosed with mantle cell lymphoma”,

which reported the findings of our study (Incidence trends of mantle cell lymphoma in the United States between 1992

and 2004. Zhou Y, et al, Cancer. 2008, August 15; 13(4):791-798). See weblink:

http://www.ahrq.gov/research/feb09/0209RA16.htm.

16. On April 13, 2009, the official journal of the American Cancer Society Cancer issued a press release for our article

entitled “Racial Disparities and Treatment Trends in a Large Cohort of Elderly Black and White Patients with Non-Small

Cell Lung Cancer” (Published Online: April 13, 2009. Print Issue Date: May 15, 2009). The findings were also reported in

HealthDay website (4/13/09), UTHSC-H (4/13/09) and about 50 media outlets across the country. This study was also

reported in the October 2009 issue of the newsletter ‘Research Activities’ of the Agency for Healthcare Research and

Quality (AHRQ).

17. On April 27, 2009, the official journal of the American Cancer Society Cancer issued a press release for our article

entitled “Review of Major Adverse Effects of Androgen Deprivation Therapy in Men with Prostate Cancer” (Published

Online:, 2009. Print Issue Date: June 1, 2009). The findings were also reported in websites such as ScienceDaily

(4/27/2009).

18. The July 2009 issue of the newsletter ‘Research Activities’ of the Agency for Healthcare Research and Quality

(AHRQ) published an article entitled “Studies explore survival and treatment disparities among black and white elderly

patients with cancer”, which reported the findings of our two studies (Ethnic variation in diagnosis, treatment,

socioeconomic status, and survival in a large population-based cohort of elderly patients with non-Hodgkin lymphoma."

(Cancer. 2008;113:3231-41) and Racial disparities and treatment trends in a large cohort of elderly African Americans

and Caucasians with colorectal cancer, 1991 to 2002." (Cancer. 2008;113:3400-9). See Link:

http://www.ahrq.gov/research/jul09/0709RA7.htm.

19. On August 17, 2009, our article “Du XL, Xia R, Liu CC, Cormier JN, Xing Y, Chan W, Hardy D, Burau KD. Cardiac

Toxicity Associated with Anthracycline-Containing Chemotherapy in Older Women with Breast Cancer. Cancer. 2009

Aug 11; [Epub ahead of print]” was featured on our MDLinx.com site today. See Link:

http://www.mdlinx.com/hemeonclinx/news-article.cfm/2840535.

20. The October 2009 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Blacks are

less likely than whites to receive lung cancer treatments”, which reported the findings of our study (Hardy D, Liu CC, Xia

R, Cormier JN, Chan W, White A, Burau KD, Du XL. Racial Disparities and Treatment Trends in a Large Cohort of

Elderly Black and White Patients with Non-Small Cell Lung Cancer. Cancer. 2009;115:2199-2211). See Link:

http://www.ahrq.gov/research/oct09/1009RA17.htm.

21. The November 2009 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Older

black women with breast cancer do not receive beneficial chemotherapy as often as white women”, which reported the

findings of our study (Bhargava A, Du XL. Racial and Socioeconomic Disparities in Adjuvant Chemotherapy for Node-

Positive Operable Breast Cancer in Older Women. Cancer. 2009 July 1;115:2999-3008). See Link:


22. The December 2009 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Men with

prostate cancer who receive androgen deprivation therapy are at elevated risk of bone fractures, cardiovascular mortality,

and diabetes”, which reported the findings of our study on “Review of major adverse effects of androgen-deprivation

therapy in men with prostate cancer” (Cancer. 2009;115:2388-2399). See weblink:

http://origin.www.ahrq.gov/research/dec09/1209RA16.htm.

http://us.cisionpoint.com/ListPage.aspx?id=64306815



http://www.ahrq.gov/research/feb09/0209RA16.htm





http://www.ahrq.gov/research/jul09/0709RA7.htm

http://www.mdlinx.com/hemeonclinx/news-article.cfm/2840535



http://www.ahrq.gov/research/oct09/1009RA17.htm






http://origin.www.ahrq.gov/research/dec09/1209RA16.htm


of 40

23. The April 2010 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Chemotherapy

that contains anthracyclines is associated with later cardiac illness in breast cancer patients”, which reported the findings

of our study on “Cardiac toxicity associated with anthracycline-containing chemotherapy in older women with breast

cancer” (Cancer. 2009;115:5296-5308.). See weblink: http://www.ahrq.gov/research/apr10/0410RA8.htm.

24. The June 2010 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Nonplatinum

chemotherapy agents more likely to lead to hospitalizations for older women with ovarian cancer”, which reported the

findings of our study on “Risk of hospitalizations associated with adverse effects of chemotherapy in a large community-

based cohort of elderly women with ovarian cancer” (International Journal of Gynecological Cancer. 2009;19:1314-

1321). See weblink: http://www.ahrq.gov/research/jun10/0610RA5.htm.

25. On July 12, 2010, the official journal of the American Cancer Society Cancer issued a press release for our article

entitled “Disparities in Colorectal Cancer Survival: To What Extent Are Racial Disparities Explained by Differences in

Treatment, Tumor or Hospital Characteristics?” (Published Online: July 12, 2010. Print Issue Date: August 15, 2010). The

findings were also reported in UTHSC-H (UTHealth) website (7/12/10), NewsWise

(http://www.newswise.com/)(7/12/10), USNEWs-HealthDay (7/16/10), and ASPH Friday Letter (7/23/10).

26. The September 2010 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Blacks

with lung cancer have higher mortality rates than whites”, which reported the findings of our study on “Racial disparities

and survival for nonsmall-cell lung cancer in a large cohort of black and white elderly patients” (Cancer. 2009;115: 4807-

4818). See weblink: http://www.ahrq.gov/research/sep10/0910RA6.htm.

27. The September 2010 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Benefits

of chemotherapy for elderly patients with lung cancer must be weighed against risk of long-term toxicities”, which

reported the findings of our study on “Chemotherapy-associated toxicity in a large cohort of elderly patients with non-

small cell lung cancer” (Journal of Thoracic Oncology. 2010;5:90-98). See weblink:

http://www.ahrq.gov/research/sep10/0910RA29.htm.

28. The February 2011 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Poorer

patients less likely to receive specific treatment for head and neck cancer”, which reported the findings of our study on

“Evaluation of trends in the use of intensity-modulated radiotherapy for head and neck cancer from 2000 through 2005”

(Cancer. 2010;116:3505-12). See weblink: http://www.ahrq.gov/research/feb11/0211RA25.htm.

29. The March 2011 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Colony-

stimulating factor is effective in reducing infection for elderly patients with non-Hodgkin's lymphoma on chemotherapy”,

which reported the findings of our study on “Comparative Effectiveness of White Blood Cell Growth Factors on

Neutropenia, Infection, and Survival in Older People with Non-Hodgkin's Lymphoma Treated with Chemotherapy” (J Am

Geriatr Soc. 2010;58(10):1885-95). See weblink: http://www.ahrq.gov/research/mar11/0311RA11.htm.

30. The March 2011 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Blacks have

worse colorectal cancer survival rates than whites”, which reported the findings of our study on “Disparities in Colorectal

Cancer Survival: To What Extent Are Racial Disparities Explained by Differences in Treatment, Tumor or Hospital

Characteristics?” (Cancer. 2010;116(19):4622-31). See weblink: http://www.ahrq.gov/research/mar11/0311RA19.htm.

31. The March 2011 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Medicare-

insured patients with head or neck cancer differ little in mortality risk because of race or ethnicity”, which reported the

findings of our study on “Racial/Ethnic Disparities in Socioeconomic Status, Diagnosis, Treatment and Survival among

Medicare-insured Men and Women with Head and Neck Cancer” (J Health Care Poor Underserved. 2010;21(3):913-

930). See weblink: http://www.ahrq.gov/research/mar11/0311RA20.htm.

32. On May 5, 2011, American Association for Cancer Research (AACR) issued a press release for our article (White A,

Vernon SW, Franzini L, Du XL. Racial and Ethnic Disparities in Colorectal Cancer Screening Persisted Despite

Expansion of Medicare's Screening Reimbursement. Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):811-7):


http://www.ahrq.gov/research/apr10/0410RA8.htm


http://www.ahrq.gov/research/jun10/0610RA5.htm

http://www.newswise.com/)(7/12/10)


http://www.ahrq.gov/research/sep10/0910RA6.htm




http://www.ahrq.gov/research/feb11/0211RA25.htm


http://www.ahrq.gov/research/mar11/0311RA11.htm






of 40

http://www.aacr.org/home/public--media/aacr-in-the-news.aspx?d=2366. The findings were also reported in UTHealth,

HealthDay News, ScienceDaily, MedicalNews, MDNews, and HealthWorldWeb.

33. The June 2011 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Chemotherapy

and radiation therapy for lung cancer linked to cardiac disorders”, which reported the findings of our study published in

Annals of Oncology. 2010 Sep;21(9):1825-33. See weblink: http://www.ahrq.gov/research/jun11/0611RA17.htm.

34. The September 2011 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Minority

patients with nonsmall-cell lung cancer are less likely to receive hospice services than whites”, which reported the

findings of our study published in Cancer. 2011;117 (7):1506-1515. See weblink:


35. Our research article “Racial disparities in the use of hospice services according to geographic residence and

socioeconomic status in an elderly cohort with nonsmall cell lung cancer” has been named as one of the top clinical

cancer research advances of the year and featured in 2011 Clinical Cancer Advances: ASCO’s Annual Report on

Progress Against Cancer (pages 30-32), which was published online on December 5, 2011 in the Journal of Clinical

Oncology and is available from www.Cancer.Net.

36. The September 2012 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Several

factors influence completion of chemotherapy in elderly patients with stage-III colon cancer”, which reported the findings

of our study published in Medical Oncology. 2011;28:1062-74. See weblink:


37. The November 2012 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled

“Radiation therapy linked to dry mouth in elderly patients with head and neck cancers”, which reported the findings of our

study published in American Journal of Therapeutics. 2011;18: 206-215. See weblink:


38. The UTSPH (1/23/2013), ASPH Friday Letter (1/26/2013), and News on the Go (1/29/2013) reported our recent

research findings funded by the AHRQ: “UTSPH researchers compare the effectiveness of chemotherapy options for

ovarian cancer”. See weblink: https://sph.uth.edu/2013/01/utsph-researchers-compare-the-effectiveness-of-chemotherapy-

options-for-ovarian-cancer/, http://fridayletter.asph.org/press.cfm?FL_Index=1762, and

https://inside.uthouston.edu/notg/index.htm.

39. The January 2013 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Elderly

colon cancer patients receiving chemotherapy after surgery are at risk for various toxicities”, which reported the findings

of our study published in American Journal of Clinical Oncology. 2012;35:228-236. See weblink:

http://www.ahrq.gov/legacy/research/jan13/0113RA17.htm.

40. The June 2013 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Combination

chemotherapy increases the risk for adverse events in elderly patients with colorectal cancer”, which reported the findings

of our study published in Annals of Oncology. 2012;23:1053-11. See weblink:

http://www.ahrq.gov/news/newsletters/research-activities/13jun/0613RA40.html.

41. The ‘MedicalResearch.Com’ reported (11/13/2014) our recent research findings funded by the AHRQ and CPRIT:

“Colon Cancer: Improved Screening and Chemotherapy Contribute To Improved Survival”. See weblink:

http://medicalresearch.com/cancer-_-oncology/colon-

cancer/colon_cancer_improved_screening_and_chemotherapy_contribute_to_improved_survival/8950/#more-8950.

42. On August 11, 2015, UTHealth issued a press release (https://www.uth.edu/media/story.htm?id=fcfafe64-039f-4de7-

baaa-4e0e93858256) for our research article (Du XL, et al. Comparative Effectiveness of Chemotherapy Regimens in

Prolonging Survival for Two Large Population-based Cohorts of Elderly Adults with Breast and Colon Cancer in 1992-

2009. J Am Geriatrics Society. 2015 July 22). The findings were reported in 35 news outlets, including

HealthinAging.org, Science Daily, MedicalXPress.com, NursingTime.Net, ScienceNewsLine, TheStatesman,

http://www.aacr.org/home/public--media/aacr-in-the-news.aspx?d=2366


http://www.ahrq.gov/research/jun11/0611RA17.htm



http://www.cancer.net/





https://sph.uth.edu/2013/01/utsph-researchers-compare-the-effectiveness-of-chemotherapy-options-for-ovarian-cancer/

https://sph.uth.edu/2013/01/utsph-researchers-compare-the-effectiveness-of-chemotherapy-options-for-ovarian-cancer/

http://fridayletter.asph.org/press.cfm?FL_Index=1762

https://inside.uthouston.edu/notg/index.htm


http://www.ahrq.gov/legacy/research/jan13/0113RA17.htm


http://www.ahrq.gov/news/newsletters/research-activities/13jun/0613RA40.html

http://medicalresearch.com/cancer-_-oncology/colon-cancer/colon_cancer_improved_screening_and_chemotherapy_contribute_to_improved_survival/8950/#more-8950

http://medicalresearch.com/cancer-_-oncology/colon-cancer/colon_cancer_improved_screening_and_chemotherapy_contribute_to_improved_survival/8950/#more-8950

https://webmail.uth.tmc.edu/owa/redir.aspx?C=NoRlc_vu3kmM0fRXyx5MGsBvdL19qdIITNweTnAj46Ol4V6TUTJHk0E1aYXVaep3MOvlobRYEE4.&URL=https%3a%2f%2fwww.uth.edu%2fmedia%2fstory.htm%3fid%3dfcfafe64-039f-4de7-baaa-4e0e93858256

https://webmail.uth.tmc.edu/owa/redir.aspx?C=NoRlc_vu3kmM0fRXyx5MGsBvdL19qdIITNweTnAj46Ol4V6TUTJHk0E1aYXVaep3MOvlobRYEE4.&URL=https%3a%2f%2fwww.uth.edu%2fmedia%2fstory.htm%3fid%3dfcfafe64-039f-4de7-baaa-4e0e93858256


of 40

ETHealthWorld.com, AJMC-ManagedMarketsNetwork, News-Medical.net, Yahoo News, Dallas Sun,

MedicalNewsToday.com, thenewsworthly.com, inquisitr.com, breastcancer.org, and ASPPH Newsletters.

43. On October 31, 2016, UTHealth issued a press release (https://www.uth.edu/media/story.htm?id=d18c5243-ecc0-

4e63-9469-0f26172f217a) for our research article (Farias AJ, Du XL. The association between out-of-pocket costs,

race/ethnicity, and adjuvant endocrine therapy adherence among Medicare patients with breast cancer. Journal of Clinical

Oncology. 2016 Oct 31). The findings were reported in 45 news outlets, including Reuters Health (11/1/16), ASCO’s

Cancer in the News (11/1/16), FoxNewsHealth (11/1/16), ScienceDaily (11/1/16), Hospital CFO (11/1), HiTechDays

(11/3/16), ASPPH News (11/3/16), and The Insider (11/7/16).

https://www.uth.edu/media/story.htm?id=d18c5243-ecc0-4e63-9469-0f26172f217a

https://www.uth.edu/media/story.htm?id=d18c5243-ecc0-4e63-9469-0f26172f217a

curriculum vitae name xianglin l. du, mb, ms, phd · pdf filecurriculum vitae update: october...

Documents